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Catechols are found in nature taking part in a remarkably broad scope of biochemical 
processes and functions. Though not exclusively, such versatility may be traced back to several 
properties uniquely found together in the o -dihydroxyaryl chemical function; namely, its 
ability to establish reversible equilibria at moderate redox potentials and pHs and to 
irreversibly cross-link through complex oxidation mechanisms; its excellent chelating 
properties, greatly exemplifi ed by, but by no means exclusive, to the binding of Fe 3 + ; and 
the diverse modes of interaction of the vicinal hydroxyl groups with all kinds of surfaces of 
remarkably different chemical and physical nature. Thanks to this diversity, catechols can be 
found either as simple molecular systems, forming part of supramolacular structures, 
coordinated to different metal ions or as macromolecules mostly arising from polymerization 
mechanisms through covalent bonds. Such versatility has allowed catechols to participate in 
several natural processes and functions that range from the adhesive properties of marine 
organisms to the storage of some transition metal ions. As a result of such an astonishing 
range of functionalities, catechol-based systems have in recent years been subject to intense 
research, aimed at mimicking these natural systems in order to develop new functional 
materials and coatings. A comprehensive review of these studies is discussed in this paper.  
Introduction. 
 
Catechols are benzene derivatives with two neighboring (orto-) hydroxyl groups, ubiquitously 
spread in nature. For example, catecholamine neurotransmitters,[1] such as adrenaline and 
noradrenaline, fulfill essential and well-defined biochemical roles. But catechol derivatives can 
also be found as active species in a variety of environments, displaying a remarkable degree of 
chemical and physico-chemical versatility that has already inspired, and is still leading to, an 
ever-growing number of applications as functional materials. In this regard, this review will 
focus on past and recent studies involving the design and biomimetic use of synthetic 
catecholic molecules in biomedics, analytical (bio)chemistry, nanotechnology and materials 
science, showcasing the unique potential of this chemical functionality to afford 
multidisciplinary approaches to scientific research, while offering at the same time promising 
candidate structures for technologically relevant applications. 
With regard to function, catechols may be broadly classified as follows: 
 SWITCH, where catechol moieties function as responsive units to external stimuli 
 SCAFFOLD, where catechol blocks build 2D or 3D structures, either by polymerization 
or self-assembly, which are functional on their own 
 HOOK, in which catechol moieties make up complex systems in which they serve as 
individual binding sites to isolated molecules 
 ANCHOR, where, either as part of complex systems or by themselves, catechol 
moieties act as passive links to surfaces and/or covalent supports to other (functional) 
moieties 
Accordingly, this review has been structured in eight different sections, where the prominent 
functional role of the catechol moiety is first exemplified by natural counterparts. In Sections 1 
to 4, we will discuss the use of catechol derivatives to anchor molecules and polymers to an 
astonishing variety of surfaces (both nano/micro- and macroscopic), which currently constitute 
perhaps their fastest growing field of application. Section 5 will present studies where 
catechols are shown to polymerize in oxidizing conditions to build up complex, polymeric 
scaffolds with excellent properties as surface coatings and incipient potential as functional 
materials. The ability of catechol groups to coordinate effectively anionic and cationic species, 
but especially transition metals such as FeIII, in therapeutic, analytical and environmental 
applications will be reviewed in Section 6. Finally, Sections 7 & 8 will deal with examples of the 
reversible redox activity of catechols, which together with their strong ability to couple to 





Mussel-adhesive proteins have been the subject of intensive scientific research over the past 
decades,[2,3,4,5] particularly because of the remarkable ability of several marine invertebrates to 
strongly adhere to virtually all surfaces, -even low-fouling materials, such as paraffin and 
Teflon®-,[4,6] and more distinctively, to do so in wet conditions that are typically conducive to 
adhesion failure.[4] In order to pin down the source of this robust adhesion, detailed studies on 
the blue mussel (Mytilus edulis) and other sessile species[7,8] have been carried out in the past 
years. To hold fast to surfaces, mussels secrete a transparent, gel-like proteinaceous substance 
that hardens with time into strong adhesive threads, with concomitant darkening.[9,10] All five 
mussel foot proteins (Mefp) unique to the adhesive plaque, albeit diverse in structure, present 
relevant common features, such as recurring sequence motifs,[11] but more importantly, 
varying amounts of the non-essential catecholic aminoacid DOPA (3,4-
dihydroxyphenylalanine), ranging from 2 to ca. 30%.[2,6,10] Either free, functionalized in simple 
variant forms, or as part of polypeptidic backbones, DOPA is widely distributed in most phyla 
of the animal kingdom, where it plays an astounding variety of biochemical roles.[7] With 
regard to adhesion in Mefps, DOPA was identified by Waite and co-workers as unique in that it 
may serve two essential purposes:[12] on the one hand, as a catecholic anchor, it is able by itself 
to chemisorb to surfaces by using diverse mechanisms, such as metal bidentate 
coordination[13,14,15,16] and hydrogen bonding;[3,4,11] on the other hand, it oxidizes easily -both 
by chemical and enzymatic methods- to the corresponding DOPA-quinone, which is then able 
to act as cross-linking unit, either by reacting with nucleophilic groups in the polypeptidic 
matrix by means of Michael-type additions, or via direct free-radical aryl-aryl 
couplings.[4,6,11, 17 , 18 ] Other physico-chemical mechanisms, such as -  stacking,[ 19 ] 
conformational rearrangements arising from tautomerization mechanisms on side chains 
following catechol oxidation,[ 20 ] and the presence of other aminoacid residues in the 
polypeptidic backbone as coadjuvants of adhesion,[8,21,22] have also been cited as contributors 
to overall cohesion and adhesion properties shown by Mefps. In an interesting twist of the 
versatility of catechol physico-chemistry, recent evidence suggested that bacteria may use 
catecholic siderophores –otherwise unrelated to DOPA units in Mefps- to attach themselves to 
surfaces in the initial stages of formation of biofilms.[23,24]  
Early attempts at obtaining a wet adhesive biomimic of Mefps were aimed at synthesizing 
oligopeptidic analogues based on repetitive aminoacid sequences, and other adhesive 
proteins.[6,9,25,26] More recently, a simplified approach based first on random co-polymers with 
catecholic moieties[27,28] and, alternatively, on carefully designed polymeric scaffolds,[29 ] 
together with a careful study of the influence of key parameters -DOPA content, nature of 
adherend and oxidizing conditions- on the performance of the prospective adhesives,[27,30] 
signified a conceptual leap that provided a solid basis for most recent investigations. For 
instance, it was found that whereas adhesion increases roughly proportionally with increasing 
DOPA content,[19,27] o-quinones exhibit much lower adhesion to metal surfaces than parent 
catechols,[18,19,27,30,31] and virtually no adhesion to other surfaces, such as mica.[19] Therefore, 
the successful design of adhesives based on macromolecular materials with pendant DOPA, -or 
by extension, catecholic- units would need to strike a balance between interfacial adhesion 
and bulk cohesiveness, by finding the degree of overall oxidation that affords an optimal 
mixture of catecholic and o-quinoid moieties.[6,27] Even when alternative cross-linking 
mechanisms have been used, such as FeIII-mediated coordination[32,33] or photo-curing,[34] 
optimal adhesion still called for a careful adjustment of the extent of cross-linking.[32,35] By 
contrast, in cases where reactive functional groups in the adherend surface material were 
likely to link covalently to the oxidized moieties, such as pig skin[31] and an amine-
functionalized Si substrate,[13] an increase in the degree of oxidation was shown to enhance 
adhesion to the surface, with rupture values in tensile tests consistent with the breakage of 
covalent bonds formed in the cross-linking stage.[13] 
This ability of catechol derivatives to interact with surfaces has been exploited by many 
scientists worldwide to prepare new synthetic functional adhesives and coatings (vide infra). 
However, understanding the basic behaviour and assembly of catechols on surfaces still 
remains a challenge. To gain more insight into this issue, Ruiz-Molina et al. have reported new 
basic studies studying the self-assembly and interaction of catechols with surfaces by 
combined theoretical calculations and scanning tunneling microscopy (STM), which allows the 
direct observation of the molecular self-assembly processes on surfaces with molecular 
resolution.[36] The results indicates that the mechanism for the strong adhesion of catechols on 
surfaces is of energetic (interactions on the surface) but mainly of thermodynamic (solvent 
effects) origin, opening new insights into the behaviour  of  catechol  molecules  on surfaces  as  
well on 2-D molecular suprastructures. Moreover, the thermodynamic control over the 
differential adsorption of an alkylcatechol and the nonanoic solvent molecules has been used 
to induce a new temperature-induced switchable interconvesion on surfaces with two 
different phases differing in their crystal packing that coexist upon increasing or decreasing the 
temperature.[37]  
Alongside excellent specific monographs recently dedicated to this fast-growing subject,[10,38] a 
survey of representative studies follows, covering recent advances in this research field, and 
representing a wide variety of potential applications with technological relevance. 
 
1.1. General purpose adhesives. 
Many studies describing more or less simplified synthetic catechol-based polymeric structures 
with recognizable biomimetic features have been published in the past decade. Payne and co-
workers described the biomimetic modification of chitosan with dopamine under enzymatic 
conditions (tyrosinase). Instead of a protein, the authors chose a polysaccharide with reactive 
amino groups as suitable cross-linking matrix via Michael’s-type adducts of the o-quinone 
moieties. Although relatively long reaction times were needed, the in situ reaction yielded 
chitosan-based water-resistant adhesives with shear strengths up to 400 kPa.[39] 
Wilker et al. prepared a range of copolymers of styrene and 3,4-dihydroxystyrene, thus 
replacing the protein backbone with a saturated hydrocarbon chain, and retaining the catechol 
unit as the only functional moiety reminiscent of mussel adhesives. Using this very simplified 
approach, these synthetic polymers were oxidized in controlled conditions using a variety of 
agents, among which, those effective to cross-link the polymer (FeIII, periodate, permanganate 
and dichromate), showing the formation of adhesive layers. Despite their relatively low 
molecular weights, up to 1.2 MPa adhesion shear forces were measured for the copolymer 
with an optimized composition.[28] Very recently, the same authors reported the synthesis of a 
terpolymer of styrene, dihydroxystyrene and p-vinyltolyltriethylammonium chloride aimed at 
investigating the role of electrostatic charges in the bulk properties of mussel-mimetic 
adhesives, which in Mfp's may be played by lysine moieties. Adhesion values were found to be 
lower than those of commercial strong adhesives in dry conditions, but higher in wet 
conditions. Particularly, the introduction of ca. 7% of an electrically charged ter-monomer 
yielded a polymer with the highest degree of adhesion -2.8 MPa in dry, 400 kPa in wet 
conditions on aluminum substrates-, which then decreased with increasing content of this 
monomer, probably due to electrostatic repulsion. It was concluded that electrostatic charge 
may provide additional surface interaction to increase the adhesion of mussel-foot proteins to 
rocky substrates.[22] The same authors have recently investigated the optimization of the 3,4-
dihydroxystyrene/styrene ratio in the copolymer, and reported the strongest polymeric mussel 
protein mimic reported to date, with adhesion strengths on Al comparable to those of 
cyanacrylate glue (7 MPa).40 
The Messersmith group prepared a novel synthetic composite inspired in the composition of 
nacre, based on a DOPA-Lys-PEG polymeric cement for the layer-by-layer deposition of ca. 300 
nanometer-sized sheets of Na+-Montmorillonite clay. Results showed that even small amounts 
of the cement were enough to impart good mechanical properties to the composite. 
Furthermore, it was shown that the addition of FeIII enhanced the mechanical properties of the 
material because of DOPA-mediated coordinative cross-linking. The Young modulus of the best 
composite approached 7 GPa, comparable to that achieved with single and multi-walled 
carbon nanotubes, although still lower than that of natural nacre (ca. 250 GPa).[41] The same 
research group reported the use of a brush co-polymer to increase the interfacial shear stress 
between a metal wire and a polymer matrix. Small wires of NiTi and Ti-6Al-4V were coated 
with brushes of polymethylmethacrylate, anchored to the surface by ATRP polymerization 
using a brominated dopamine derivative. Coated wires were further cast on a PMMA block 
and subjected to a pull test to determine their adhesion to the matrix. Results showed that the 
use of the dopamine-based brush coating more than doubled the macroscopic affinity of the 
metal wires for the matrix, compared with uncoated wires.[42] As part of their research on 
biocompatible adhesives, the adhesive properties of catecholic moieties were further 
investigated by synthesizing a block methacrylic acid /methylmethacrylate copolymer with 
grafted DOPA units. This polymer was then used to fabricate an adhesive elastic membrane, 
with which pressure adhesion tests on TiO2 and pig skin surfaces were carried out. After 
repeated contact/removal experiments, adhesion was shown to decrease, likely due to loss of 
adhesive material on the membrane that ended up more strongly bound to the adherend 
surfaces. Interestingly, while oxidation dramatically decreased adhesion to TiO2, it improved 
binding to pig skin, probably due to the formation of covalent bonds by chemical reaction 
between oxidized DOPA units and the tissue.[31] 
The careful design of a mussel-foot-protein-mimetic polymer with grafted dopamine pendant 
groups enabled the design by the Messersmith group of dual biomimetic adhesive surface that 
combined the properties of both dry gecko- and wet mussel-foot adhesion. The peculiar 
features of gecko feet were modeled by imprinting roughness into an adhesive 
polydimethylsiloxane (PDMS) surface in the form of submicrometer pillars. This patterned, 
gecko-like adhesive surface was then coated with a 20-nm layer of a mussel-mimetic 
dopamine methacrylate/methoxyethyl acrylate copolymer. The adhesion forces of the coated 
patterned surface to silicon nitride, titanium and gold were measured by AFM in dry (air) and 
wet (underwater) conditions, and compared to those of an uncoated, patterned reference 
surface. The authors showed that, while the mussel-mimetic coating increases dry adhesion 
with regard to the uncoated reference, the most dramatic increase takes place in wet 
conditions, where dopamine-mediated surfaces on Si3N4 increased adhesion by 15-fold. 
Adhesion was also proved to be reversible, both in dry and wet conditions, over at least 1000 
cycles without significant performance loss.[43] In contrasting study, Washburn, Sitti and co-
workers prepared gecko-inspired elastomeric microfiber arrays with mushroom-shaped tips, 
which were coated with a film of dopamine methacrylate/methoxyethyl acrylate co-polymer. 
It was shown from macroscopic –i.e., no AFM-scaled- measurements that the gecko-like 
coated surfaces adhered reversibly to glass and that gecko-like fiber patterns, coupled with the 
adhesive film, presented a cooperative effect that enhanced wet adhesion. In dry conditions, 
though, the expected contribution of the dopamine-based film on the adhesive properties of 
the gecko-like surface was found negligible[44] The same research group later showed that the 
incorporation of a very small amount of a cross-linking third monomer -ethylene glycol 
dimethacrylate (EGDMA)- in the aforementioned co-polymer scaffold was sufficient to afford a 
viscoelastic material with significantly enhanced and reversible adhesion in wet conditions,[35] 
that also improved the latter in coated gecko-like surfaces.[45] 
Polymers with catecholic pendant groups have also been tested as adhesive re-inforcers. T.G. 
Park, Lee, and co-workers successfully improved the mechanical properties of carbon 
nanotube fibers (CNF) by infiltration of a star-branched polyethylenimine-catechol[46] in the 
CNFs in the course of a post spinning treatment, which involved final densification of the 
coated CNFs by evaporation of the solvent and curing at 120ºC. The tensile strength of the 
fibers was shown to increase by 2-fold solely by infiltration, and 4-fold (up to 2.2 GPa) after 
curing. Furthermore, tensile strength of the treated fibers was shown to increase as well with 
the catechol end-group content of the polymer. Finally, the mechanical strength of the fibers 
increased almost 500% with regard to untreated fibers by further cross-linking treatment with 
FeIII.[47] 
 
1.2. Adhesive hydrogels for biomedical applications. 
As a specialty materials, adhesive hydrogels are much needed in many biomedical applications, 
such as stitch-less surgery, for which solubility in body fluids, sufficient wet adhesion, a degree 
of elasticity similar to that of soft tissues, and non-toxicity/biocompatibility are essential 
requirements for a satisfactory performance.[34,48] Furthermore, for medical applications 
hydrogels should undergo a fast sol-gel transition once in contact with the tissue, in order to 
avoid surgical delay. Because of the exceptional wet adhesion of mussel adhesives and cross-
linking abilities of catechol moieties, biomimetic hydrogels based on these have been 
researched in the past years and emerged as promising candidates to fill this challenging 
technological niche.[10]  
In one of the first simplified designs of synthetic catechol-based wet adhesives, Deming et al. 
prepared random copolymers of DOPA and lysine, which were identified as the key 
components in the adhesive properties of marine mussel proteins. In this work, primacy was 
given to the straightforward incorporation of these aminoacids into a polymeric backbone, 
rather than on achieving specific, peptide-like sequences. Prospective polymers were applied 
from aqueous solutions to aluminum and steel surfaces, and cured in aerobic and anaerobic 
(H2O2, tyrosinase) conditions. Once cross-linked, DOPA-Lys co-polymers showed strong 
adhesion to aluminum and steel surfaces, which was found proportional to the DOPA content 
and dependent on the choice of oxidation conditions and oxidizing agent. An important 
conclusion of this study was the observation that the oxidative mechanism involved in the 
cross-linking increased the cohesion of the adhesive, but at the same time oxidized catechol 
residues to the corresponding o-quinones, thus reducing the overall adhesion to surfaces.[27]  
Following another simplified approach, Messersmith and co-workers designed different linear 
and star-branched frameworks with DOPA end-caps as adhesive/cross-linkable moieties, and 
biocompatible PEG for the hydrogel-forming central scaffold. Four different DOPA-capped 
PEG-polymers were synthesized, paying attention to the cross-linking mechanism resulting 
from each of the different oxidizing agents tested, both chemical- and enzyme-based. Most 
polymers were shown to form gels, and all were satisfactorily cured, with cross-linked 
structures made up of three to more than six units of the original framework. Gelation time 
was found to depend on the oxidation conditions and the architecture of the PEG chains.29] 
The same group reported on a photopolymerizable DOPA-PEG-methacrylamide monomer 
intended to cure under UV irradiation. Without the need for oxidative cross-linking, this 
hydrogel was thus specifically designed to be less prone to lose adhesion by concomitant 
oxidation of the catecholic moieties. These photocured hydrogels showed elastic moduli 
considered suitable for biomedical applications.[34] Using a similar strategy with a branched, 
DOPA-terminated, PEG-polylactic acid-methacrylate block polymer, a photocured, 
biodegradable hydrogel could be prepared with an elasticity similar to that of soft tissues, and 
good adhesion to titanium surfaces in wet conditions. As in previous works, adhesion to metal 
surfaces was shown to decrease in the presence of oxidizing agents.[30] 
In more recent studies, Messersmith and co-workers have focused on the demonstration of 
the in vivo performance of catechol-PEG adhesive hydrogels. For example, a star-branched 4-
arm PEG hydrogel polymer terminated with dihydroxyhydrocinnamyl units, cross-linkable in ca. 
30s upon addition of NaIO4 was tested on diabetic mice to seal islets transplanted to their 
extrahepatic tissue. Mice were shown to recover a normal glycemic response with minimal 
inflammatory response and unchanged contact with the supporting tissue for up to one 
year.[49] The same hydrogel adhesive was shown to successfully seal punctures in model 
elastomeric membranes with an elastic response similar to that of typical fetal membranes.[50] 
For a series of biodegradable adhesive polymers, a similar, star-branched design based on 
catecholic ends -dopamine, dihydroxycinnamic acid-, polyethylene glycol (PEG), and 
polycaprolactone (PCL), was utilized. These polymers could be cast into films, and their 
mechanical properties, extent of swelling, and degradation rate were tailored through the 
composition of the polymers as well as blending with additives. When coated onto a biologic 
mesh used for hernia repair, these adhesive composites demonstrated wet-resistant adhesion 
properties, with strengths significantly higher than that of fibrin glue,[51] and ca. 60% of that of 
a cyanacrylate-based adhesive. When a coating of this bioadhesive was applied to sutured 
porcine Acchiles tendons, the stiffness and failure load of the suture increased by roughly 
30%.[52] 
Stewart and co-workers have recently reported on adhesive hydrogels formed by complex 
coacervation. In one example, the authors showed that a mixture of a modified gelatin and a 
negatively charged copolymer of dopamine metacrylate and ethylphosphate metacrylate, 
gelates at basic pHs. The cohesion of the adhesive gel was enhanced by the presence of CaII 
and MgII cations, which were used to adjust the coacervation temperature to biological 
conditions. Cohesive strength was further enhanced by oxidative cross-linking with NaIO4. The 
authors indicated that this coacervate would biodegrade, which would make it particularly 
suitable for biomedical applications.[53] In another study, an adhesive formed by complex 
coacervation of a copolymer of methacrylamide and an alquilammonium acrylamide 
(positively charged), and a terpolymer of dopamine metacrylate, methacrylamide and 
ethylphosphate methacrylate, was shown to gelate at ph>4. The gel showed an adhesion force 
to hydroxyapatite up to ca. 40% that of cyanacrylate glues.[54] 
T.G. Park and co-workers prepared an injectable hydrogel by cross-linking catechol-grafted 
hyaluronic acid and a thiol-capped Pluronic® polymer. Cross-linking was assumed to take place 
via Michael addition of the thiol groups to oxidized catechol (i.e. o-quinone) moieties. The 
hydrogels showed longer-lasting stability and improved adhesion to biological tissues.[55] In a 
follow-up study, a hydrogel was synthesized by cross-linking catechol-derivatized chitosan and 
a thiol end-capped Pluronic® F127 – a block copolymer of ethylene oxide and propylene oxide-. 
The thiolated polymer was intended for fine-tuning of the gelation speeds to adequate values 
for good tissue-repair at biological temperatures. The resultant hydrogels showed excellent in 
vivo performance, with the chitosan scaffold conferring haemostatic properties, and the 
catechol pendant groups, improved solubility and strong adhesion to wet mucoses and 
tissues.[ 56 ] Following a similar modular approach in which dopamine moieties provide 
anchoring points for functional polimeric coatings, Ishihara, Huang et al. recently fabricated a 
hemocompatible, polymetacrylic acid-dopamine metacrylate-phosphorylcholine metacrylate 
terpolimer that resists platelet adhesion, while robustly adhering to Ti surfaces intended for 
cardiovascular implants.57 
 
1.3. Metal cross-linked adhesives. 
The outer cuticle of byssal threads of marine mussels is made up mainly of mussel foot protein 
Mfp-1, a peptide that contains ca. 10-15% of catecholic aminoacid 3,4-dihydroxyphenyl-L-
alanine (DOPA).[58] As extracted, mfp-1 is known to carry a certain amount of FeIII, a sizeable 
fraction of which remains tightly bound to the protein even after treatment with strong 
chelators (EDTA) and acidic conditions.[59] Waite and co-workers showed that both mfp-1 and 
several DOPA-containing oligopeptide fragments of this protein are able to coordinate FeIII 
forming bis-catecholato complexes at physiological pH, and tris-catecholato complexes in 
slightly basic conditions.[60] The high stability of these coordination complexes, reminiscent of 
those of siderophores, would explain how mussels are able to keep and enrich their byssus 
with this metal. The same authors suggested that, with as many as 150 DOPA residues per 
peptide molecule, mfp-1 in coordination with equivalent amounts of FeIII would afford a 
feasible cross-linking strategy, notwithstanding other possible mechanisms.[58] The Wilker 
group studied DOPA-containing Mfp-1 & Mfp-2 protein extracts by ESR after treatment with 
controlled amounts of Fe(NO3)3 in both aerobic and anaerobic conditions. It was shown that 
upon coordination with a third unit of DOPA and in the presence of oxygen, an ESR signal 
corresponding to an organic radical shows up, at the same time that the FeIII signal decreases, 
indicating that upon full metal coordination, FeIII is reduced to low-spin FeII. Concomitantly, an 
electron is transferred to a DOPA unit, generating a reactive semiquinone which can further 
react to generate a further cross-linked, covalent structure. Thus, in aerobic conditions, both 
FeIII-coordination and radical-mediated covalent cross-linking would contribute to the build-up 
of mussel adhesive.[61,62] Loizou et al. studied the effect of the addition of FeIII in the presence 
of oxygen on the morphologic and rheological properties of mussel adhesive protein extract. 
At the microscale, the initial porous hydrogel was seen to become more rigid and compact 
after the addition of the metal, which correlated with a more solid-like, elastic material.[63] 
Further work on the mfp-1 protein showed that it is able to adhere to mica surfaces, but does 
not have the cohesive behavior necessary to glue two coated surfaces together.[ 64 ] 
Nevertheless, the same surfaces could be bound together with the addition of a certain 
amount of FeIII. In this case, the metal must coordinate, to a certain extent, DOPA moieties 
belonging to mfp-1 chains located on opposite surfaces, offering the necessary degree of 
cross-linking for adhesive cohesiveness. It was also shown that an excess of FeIII was 
detrimental to cohesion, likely because the coordination number of the cation decreases when 
its concentration is raised.[65] More recently, the Waite group showed that the inner structure 
of the byssal thread cuticle is a composite-like material made of an elastic protein matrix in 
which harder granules are dispersed. Using confocal Raman spectroscopy, it was found that 
the concentration of FeIII in the granules exceeded that of the matrix. Since differences in 
mechanical properties between phases correlate with the FeIII content in each phase, it was 
concluded that FeIII participates in the in vivo cross-linking of the protein.[66,67] Moreover, 
because as opposed to covalent links, catechol-FeIII bonds are strong, yet reversibly breakable, 
cross-linked proteins in byssal threads may likely self-heal in their natural environment by 
means of DOPA-FeIII coordination.[68] In another study, the application of computer aided 
design (CAD) to the patterning of various mussel adhesive proteins using piezoelectric inkjet 
technology was explored. FeCl3 solutions were applied as cross-linkers, and test performances 
were compared against those of commercial cyanacrylate glues. Cross-linking was found to be 
effective at stoichiometric FeIII/DOPA ratios, while adhesion decreased with FeIII in excess. 
Although synthetic adhesives were still found superior in terms of strength, this study showed 
the potential of environmentally-friendly bioadhesives in microsutures.[69] 
In addition to adhesive proteins from natural sources, a few synthetic mimics have been 
studied with regard to FeIII cross-linking. A range of copolymers of styrene and 3,4-
dihydroxystyrene were prepared as simplified models of natural DOPA-containing peptides. 
After deprotection of the hydroxyl groups and controlled oxidation of the polymers with a 
variety of agents, FeIII was found, among others, to cross-link the polymer forming adhesive 
layers.[28] FeIII-mediated cross-linking was applied in a biomimetic fashion to the design of a 
synthetic self-healing hydrogel. A branched DOPA-modified PEG polymer was first mixed with 
FeIII in a 1:3 ratio at acidic pH. After the initial development of a green color, typical of mono-
catecholato-Fe complexes, subsequent addition of controlled amounts of NaOH up to pH~12 
induced color changes, characteristic of the sequential formation of bis- and tris-DOPA 
complexes. Whereas the initial mixture was found to be essentially viscous at low pH, the FeIII 
cross-linked material had a sticky gel consistency and elastic behavior, with rheological 
properties close to those of a reference polymer alternatively cross-linked in a fully covalent 
fashion with NaIO4. More importantly, Fe
III-cross-linked gels were self-healing while periodate-
cured gels were not, which was attributed to the reversible recovery of the FeIII-DOPA 
coordination network after shear-induced failure.[32] Very recently, del Campo and co-workers 
reported on a biocompatible, FeIII-crosslinkable hydrogel bearing 5-nitrodopamine moieties. In 
addition to the self-healing properties of this kind of metal-crosslinked polymers, the presence 
of the nitro group enabled the on-demand debonding of the adhesive upon light exposure.70 
In addition to FeIII, a self-healing effect via catechol-mediated cross-links has been achieved as 
well by taking advantage of the pH-mediated, reversible nature of the boron-catechol bond. A 
branched catechol-derivatized PEG was reacted with 1,3-benzenediboronic acid at pH = 9 to 
yield a hydrogel cross-linked with boronate ester groups, which reverted to the uncross-linked, 
viscous liquid state after adjustment to pH = 3. The covalent nature of the cross-linked 
hydrogel state was found to be consistent with its rheological properties, showing stickiness 
and self-healing properties, sealing cuts seamlessly within 30 seconds.[71] 
2. Functionalizable platforms (Primers). 
 
Polydopamine has emerged in recent years as a virtually universal bio-inspired coating 
material and adhesive primer. Its use was pioneered by Messersmith and co-workers,[72] who 
described an easy, straightforward coating method consisting of the aerobic auto-oxidation of 
dopamine in mildly basic aqueous buffered media, and in situ spontaneous deposition of the 
resulting polymer on a wide variety of substrates, ranging from inorganic (metals, metal 
oxides) to organic (polymers), including notoriously difficult materials, such as PTFE, with a 
remarkably wide-ranging effectiveness reminiscent of mussel adhesive proteins.[73] More 
importantly, the authors showed that, in addition to its versatile coating abilities, 
polydopamine thin films allowed the immobilization of many organic species on top, opening 
up the possibility to use polydopamine-mediated chemistry as a generic way to coat substrates 
with functional organic adlayers.[72,74] In this regard, it was assumed that  successful binding of 
the top adlayer would involve Michael- and/or Schiff-base-type reactions between nucleophilic 
groups –such as amines and thiols- in the functional molecule and residual, electrophilic o-
quinoid moieties in the polydopamine film, resulting from the existence of at least a residual 
fraction of oxidized moieties in the polymer.[72] More specifically, the Messersmith group 
demonstrated a generic strategy for the immobilization of biomolecules involving coating of 
the substrate by polydopamine, followed by reaction of nucleophiles -typically, amines or 
nucleophilic amine residues, which are common in complex biomolecules- with polydopamine 
film. In a competitive assay that employed lysine and hystidine, it was shown that it is possible 
to discriminate between nucleophiles by their respective rates of addition to the adhesive 
film.[75] In addition to the ability to form covalent bonds with ad-layers, residual redox activity 
arising from coexisting catecholic and o-quinoid moieties in the polymeric backbone has been 
shown to play a significant additional role in the reactivity of polydopamine films.[76,77] It is 
worth mentioning here that, notwithstanding its usefulness as adhesive primer, the structure 
of polydopamine is still subject of debate. In this regard, it has been recently related to that of 
eumelanin78 and, in contrast with the common understanding so far, it has been suggested to 
be essentially made up of monomeric units of 5,6-dihydroxyindoline and its quinoid derivative 
that self-aggregate by a combination of charge transfer, π-stacking, and hydrogen bonding 
interactions.79 
Although most of the work on polymeric adhesive primers by Messersmith’s and other groups 
has favored polydopamine, norepinephrine has also been studied as an alternative tool for 
facile catechol-based surface modification. Because of their structural similarities, dopamine 
and norepinephrine are amenable to analogous oxidative polymerization methods. On the 
other hand, norepinephrine is complementary to dopamine in that it can easily activate by 
itself SI-ROMP polymerizations, thanks to the presence of a hydroxyl group in the side-chain.[80]  
In addition to the comprehensive list of materials included in Messersmith’s original proof-of-
concept work,[72,74] intensive research has been carried out in the past years regarding new 
coatable materials, -such as graphene oxide,[76] diamond-like carbon,[81] carbon nanotubes,[82] 
polylactic acid,[83] polycaprolactone nanofibers,[84,85] and yeast cells.[86] On the other hand, 
many functional adlayers, like polymeric brushes,[76,82, 87 ] aminoacids,[75] avidin,[86] 
heparin,[ 88 , 89 , 90 ] hyaluronic acid,[72, 91 ] and functional living cells,[84, 92 , 93 , 94 , 95 ] have been 
successfully immobilized on polydopamine-coated substrates. With regard to its potential use 
in biomaterials, a very recent study on the in vivo toxicity of polydopamine showed that a one-
step coating of poly-L-lactic acid with polydopamine greatly reduced the inflammatory 
response to such coated surfaces and the immunological responses of blood on coated 
quantum dots.[83] 
 
2.1. Polydopamine - General purpose applications. 
Kang, Fu and co-workers showed that dopamine may play a dual role, both as a reducing agent 
and as adhesive layer, in the preparation of functionalized graphene surfaces in mild 
conditions. Graphene oxide was coated polydopamine, which once in contact with the surface, 
reduced the GO to graphene. To this surface-modified graphene, PEG brushes were grafted 
using amino and thiol end-capped PEG, resulting in water-dispersible graphene.[76] In a similar 
study, Lee et al. used polynorepinephrine to coat/reduce GO to graphene. Further treatment 
consisted of the polymerization of -caprolactone on top of the modified graphene by SI-ROP 
polymerization techniques. The residual redox activity of the coating was shown to be able to 
reduce Ag+ to Ag nanoparticles, which ended up attached to the polymeric coating, providing 
the material with antibacterial properties.[77] A hybrid material was prepared by Zeng et al. by 
coating reduced graphene oxide with polydopamine and further incubating the modified 
surface in simulated body fluid.96 
Wang, Yang and co-workers made use of both residual electrophilic and nucleophilic activity in 
polydopamine films to sandwich them in succession between a nucleophile bottom layer and 
an electrophile top layer. Surface Si-O bonds on silicon were reacted with 
aminopropyltriexoxysilane. Once silanized, the surface was further coated with polydopamine. 
Finally, the double-coated substrate was treated with stearoyl chloride, which reacted 
presumably with pendant amino groups of dopamine. This three-tiered coating was shown to 
be very stable, which was attributed to the covalent links established between all layers. The 
micro- and macrotribological properties of the modified surface were studied, showing that 
the friction coefficient decreased significantly.[97] A similar strategy has been recently used by 
the same authors to assemble reduced graphene on silicon surfaces98. Very recently, Kim et al. 
prepared a stretchable, transparent and conductive polymer spray-deposition of silver 
nanowires on polydopamine-modified polydimethylsiloxane.99 
Zhou and co-workers used carbon nanotubes (CNTs)[82] and TiO2 nanowires
[87] as platforms to 
immobilize brush polymers via dopamine chemistry. Firstly, CNTs were coated with a layer of 
polydopamine, which then reacted with a suitable thiolated initiator. Brushes of 
polydimethylaminoethyl methacrylate (PDMAEMA) were then grown on top of the 
polydopamine layer by SI-ATRP, and further modified by quaternization of the nitrogen atoms. 
These positively charged CNTs were placed in contact with PdCl4
- solutions and subject to 
electrochemical reduction, which induced the precipitation of Pd nanoparticles on the CNTs. 
Pd-loaded CNTs showed high electrocatalytic activity for the oxidation of methanol and 
hydrazine sulfate. In the case of TiO2 nanowires, a final thermal treatment was used to 
volatilize the polymeric brush and graft the Pd NPs to the surface of the TiO2 nanowires. When 
Au nanoparticles were added to the mix, Pd-Au alloy nanoparticles attached to the nanowires 
were obtained.[100] The same research group investigated the electrodeposition of Au on a 
polydopamine-coated indium tin oxide surface. Polydopamine was shown to induce the 
crystallization of Au in a flower-like morphology, which turned out adequate for the use of 
surface-enhanced Raman scattering as a detection technique. Rhodamine 6G could thus be 
quantified at the gold surface in the pM regime.[101] The in situ precipitation of Au in the 
presence of polydopamine thus afforded Au NPs embedded in the polymeric film. A very 
similar assemblage, based on AuNPs, polyaniline and polydopamine, was used by Li and co-
workers to fabricate an electrochemical sensor for ascorbic acid down to the M range.[102] 
Very recently, Yin et al. devised a sensor for H2O2 by depositing polydopamine/Au 
NPs/horseradish peroxidase on a Au electrode. The authors claimed that the performance of 
the sensor was enhanced by the extra conductivity contributed by the Au NPs.[103] 
Finally, polydopamine has been recently shown to be amenable to microcontact printing with 
polydimethylsiloxane (PDMS) stamps. Tsai et al. successfully imprinted polydopamine on a 
variety of substrates - glass, silicon, gold, polystyrene, and PEG – after deposition of the 
adlayer on PDMS. Polydopamine patterns were subsequently modified with a variety of 
functional layers, such as cells, bovine serum albumin, reduced Ag ions in the form of Ag 
nanoparticles, and Au nanoparticles.104 A very similar strategy for the immobilization of cells 
was reported by Zhang, Jiang and co-workers.105 
 
2.2. Polydopamine - Biomedical applications. 
A few recent works have started to tap into the enormous potential of polydopamine as 
biocompatible adhesive in the biomedical field, by showing that a wide variety of biologically 
relevant substances may be successfully immobilized on substrates of choice. For instance, 
Choi and co-workers used an indirect strategy to deposit yeast cells on a substrate, by coating 
them with a polydopamine layer, subsequently functionalized with an avidin adlayer. The 
modified polydopamine layers were shown to be stable, inhibit cell division, while at the same 
time conferring certain protection to the yeast cells against enzymatic aggression. On the 
other hand, a TiO2 surface was functionalized with biotin-capped-polyPEGMA. Thanks to the 
formation of avidin-biotin complexes, coated yeast cells could be effectively immobilized on 
the TiO2 surface.
[86] The direct immobilization of living cells has found incipient application in 
biosensing techniques. For instance, polydopamine layer on a Au/polypyrrole actuator was 
shown to enhance the adhesion of bacteria and their accumulation from physiological 
media.93] In another report, Elimelech et al. showed that a single E. coli cell may be adhered to 
the tip of an AFM cantilever, once coated with polydopamine. Immobilized cells were shown to 
be alive by fluorescence techniques.[94] Recently, Nam and co-workers coated a variety of 
substrates (Au, glass, Pt, ITO) intended for use as neural surface interfaces, with 
polydopamine, and later with poly-L-lysine (PLL). Neuron cultures were not viable on 
polydopamine-only films, but they grew normally on PLL ad-layers reacted with PDA coatings. 
Moreover, PLL-polydopamine-coated microelectrode arrays were readily functional, so that 
both spontaneous and stimulated neural activity could be recorded from cultured neuronal 
networks.[95]  
H. Park et al. reported using a polydopamine layer to immobilize gelatin on a fibrous matrix of 
polylactide-co- -caprolactone. The adhesion of gelatin -a potential carrier for therapeutic 
payloads- to the matrix was thus enhanced, without impairment of its mechanical 
properties.[85] The adhesion of a lectin (concavalin A) on Au, In, Ir was demonstrated by Morris 
and co-workers by showing the selective binding of ribonuclease B (RNase B) on the modified 
surfaces.[106] Wang and co-workers immobilized bovine serum albumin (BSA) on diamond-like 
carbon surfaces via polydopamine, showing that modified surfaces present low cytotoxicity 
and good hemocompatibility.[81] In a very similar study, Tao et al. modified a silicon surface 
with a biocompatible and corrosion-resistant BSA monolayer.[107] When polydopamine was 
used to immobilize VEGF onto Ti alloy surfaces, a better attachment of human dermal 
microvascular endothelial cells (HDMECs) was observed, indicating that such modified Ti 
surfaces have potential for bone healing and regeneration applications.[108] In a similar 
application, TiO2 nanotubes were grown on Ti surfaces and coated with morphogenetic protein 
2 by using polydopamine as adhesive primer. Coated surfaces showed in vitro enhanced 
proliferation and differentiation of mesenchymal stem cells.[109] Zhang and co-workers coated 
an Au electrode intended as a biosensor with polydopamine. First, anti-(sulfate reducing 
bacteria) antibodies were immobilized on top to provide specific binding sites for detection. 
Then, bovine serum albumin (BSA) was added to block non-specific binding sites. Detection 
was possible using electrochemical techniques down to 100 colony forming units (CFU)/mL.[110] 
Polydopamine coatings were also chosen to immobilize SiO2 nanoparticles with antifungal 
activity by Ferreira et al. The NPs were first coated with dextran aldehyde, then surface-
reacted with amphotericin B, and finally immobilized on glass surfaces with polydopamine. 
While the modified NPs themselves showed high antifungal activity –stronger than that of 
colloidal silver-, and reusability without loss of therapeutic activity, polydopamine coatings 
used for their immobilization were found neither hemolytic nor cytotoxic.[111] Städler and co-
workers prepared a complex sandwich of biolayers by sequentially coating glass surfaces with 
poly-L-lysine, liposomes with a fluorescent lipidic cargo, polydopamine and myoblasts 
immobilized on top. It was shown that cells could uptake fluorescent lipids through the 
polydopamine layer. This qualitative controlled release was observed by checking the rate of 
increase of myoblast fluorescence, which was lower with increasing thickness of the 
polydopamine coating.[112] In another controlled release study, Shea and co-workers reported 
the coating of microspheres of polylactic-co-glycolic acid with several prospective 
matrices, such as polydopamine and many cationic polymers (ex. poly-L-lysine). Coated 
microspheres were subsequently loaded with plasmids and used to prepare layered scaffolds, 
intended for the in vivo controlled, sustained release and delivery of genetic material. 
Although the slowest initial release was observed with polydopamine, this coating later 
afforded the most sustained release of plasmids.[113] 
T.G. Park and co-workers prepared complex multilayer coatings for modified metal stents to be 
used as controlled release supports. For the first layer –the one directly in contact with the 
metal surface- polydopamine was used in order to immobilize a second layer of heparin on 
top. To the heparin-coated metallic surface, the authors deposited a multilayer composed of 
anionic poly(lactic-co-glycolic acid) grafted hyaluronic acid (HA-g-PLGA) micelles encapsulating 
paclitaxel, and alternating heparin layers. In this design, heparin conferred 
antithrombogenicity and hemocompatibility, whereas paclitaxel was intended as 
antiproliferation drug to suppress hyper-proliferation of smooth muscle cells. By adjusting the 
amount of heparin and HA-g-PLGA micelles, the controlled release of paclitaxel could be fine-
tuned and the proliferation of muscle cells, inhibited.[89] In a parallel study, a hyaluronic acid 
layer was immobilized on a stainless steel stent by means of dopamine chemistry. On top of it, 
a series of layers of cationic plasmid DNA/polyethylenimine (PEI) polyplexes afforded 
controlled release of pDNA.[91] C.B. Park et al. developed a simple procedure to micro-pattern 
adhesive polydopamine on non-adhesive substrates and showed that several types of living 
cells could be selectively immobilized on top of the patterned areas. It was suggested that this 
strategy may be used in the fabrication of biochips.[92] The same research group spun 
polycaprolactone in 700-nm-diameter nanofibers and further coated them with polydopamine. 
The viability of the dopamine-coated material for use in vascular grafts was tested, showing 
that human umbilical vein endothelial cells (HUVECs) exhibited highly enhanced adhesion and 
viability, increased stress fiber formation, and positive expression of endothelial cell markers, 
comparing favorably to gelatin-coated PCL material.[84] More recently, heparin has been 
successfully immobilized on polyurethane[88] and polyethylene[90] substrates in a robust way by 
pretreatment of these with dopamine. The modified substrates were shown to inhibit blood 
coagulation and platelet adhesion. Kohane and co-workers used polydopamine to improve the 
adhesion between body tissues and low-adhesion polymeric implants. Both polydopamine and 
polydopamine-PEG-RGD (adhesive peptide) composites were applied to PMMA surfaces -used 
in prosthetic cornea implants-, in order to test their adhesion to both collagen gels and soft 
tissue. Interestingly, polydopamine was shown to adhere tightly to collagen gels, while the 
peptide conjugate did not, but showed lower adhesion to tissue than the peptide conjugate. 
The conjugate coating significantly enhanced cellular proliferation of corneal epithelial cells 
and keratocytes without causing excessive secretion of pro-inflammatory cytokines.[114] 
Dopamine has been used by Kang et al. as benchmark in the investigation of other 
bioadhesives. For instance, barnacle cement was tested alongside dopamine as anchoring 
material for the immobilization of a poly-2-hydroxyethylmethacrylate (PHEMA) adlayer on a 
stainless steel substrate, to which chitosan chains were further attached. Both surface 
modifications showed excellent and similar stability and antifouling properties.[115] In another 
study, polydopamine and poly-p-hydroxystyrene (pPHS) were used as primers for several 
triazine-based polymers cross-linked with tioether linkages as suitable adhesives for fiber-
mesh-assisted bone fracture repair. It was found that the use of (poly)dopamine as primer 
coating on the (fractured) wet bone enhanced the performance of the adhesive, but shear 
strength results were still lower than those of cyanoacrylate adhesives. Nevertheless, the 
cytotoxicity of the novel adhesive/primer combinations was very low, and cyanacrylate turned 
to perform better as stand-alone adhesive than embedded in a fiber-mesh, where both the 
dopamine- and pPHS-primed triazine-based composite performed much better.[116] Lai et al. 
described the potential use of dopamine-coated magnetic NPs as adhesives for model 
contaminants in waste waters (such as bisphenol A) and bacteria (E. coli) to be later analyzed 
by capillary electrophoresis.[117] 
Wang and co-workers have recently used polydopamine as substrate for molecular imprinting 
analysis, coupled to detection by means of a quartz crystal microbalance. Sensing crystals were 
coated with polydopamine in the presence of 1,3,5-pentanetricarboxilic acid, chosen as 
innocuous analog for highly toxic domoic acid. Once the surrogate analyte was removed from 
the imprinted coating, domoic acid could be successfully detected in solution down to 5 ppb, 
below maximum residual limits established in Western countries.[118] 
Many reports have been published in the past years concerning the use of polydopamine as 
adhesive/encapsulation matrix for electrodes and sensors in general. Yin and co-workers 
deposited polydopamine to serve as an adhesive layer on a glassy carbon electrode and a 
matrix for halloysite nanotubes capable of incorporating Ru(bpy)3
2+ via cation exchange. This 
enabled the fabrication of an electroluminescent hydrophillic electrode.[119 ] A series of 
complex nanocomposites were prepared by Xie et al. using polydopamine, in order to entrap 
MWCNTs and coat a glassy carbon electrode, capable of sensing hydroquinone. More 
sophisticated variants of this nanocomposite coating were devised to detect glucose and 
prepare the biocathode of a membrane-less glucose/O2 biofuel cell (BFC).
[120] The same 
authors reported a complex nanocomposite where polydopamine is used as a matrix for 
glucose oxidase, Pt NPs, Au NPs, and antibodies. This nanocomposite material was tested in 
model amperometric immunoassays to detect human immunoglobulin G (hIgG).[121,122] 
 
2.3. Other catechol-based platforms. 
Messersmith and co-workers prepared a mussel-inspired synthetic polymer [N-(3,4-
dihydroxyphenetyl)methacrylamide–co-aminoethylmetacrylamide] to design a universal 
method of substrate coating for the immobilization of DNA onto surfaces.  The mechanism by 
which DNA ended up immobilized onto the polymeric layer was not ascertained, but the 
authors suggested, that as in the case of polydopamine, it might involve covalent bonds 
between quinone (oxidized) residues and amines & thiols on the DNA probe, as well as non-
covalent interactions between these, such as -  and hydrogen bonds. It was also 
hypothesized that both the catechol moieties on one monomer type and the free amine 
moieties on the other might contribute to versatile adhesion, in a manner reminiscent of Mfp-
5, in which both DOPA (catechol-terminated) and lysine (amine-terminated) residues make up 
50% of the total amino-acid content.[123] 
T.G. Park and co-workers functionalized a polyethyleneimine cationic polymer with dopamine 
end-caps and dopamine units grafted to an anionic hyaluronic acid polymer. These opposite-
charge polymers were then successfully deposited in a layer by layer approach on surfaces, 
such as PTFE, that usually present resistance to coating, and to LbL coating in particular, 
because of their antiadhesive properties. Other challenging surfaces that usually need priming 
prior to coating, such as PE, PET, and polycarbonate (PC), could be successfully modified as 
well. Finally, the latent redox activity of the dopamine moieties was used to anchor Ag 
nanoparticles, which provided the coated surface with antibacterial properties.[46] Catechol-
capped polyethyleneimine polymers were used very recently by Lee, Jang et al. to immobilize 
adeno-associated viruses (AAV) on substrates in micro-patterns. Cells deposited within 
modified areas were selectively infected by viruses, as opposed to outlying cells. With regard 
to spatial control of the viruses, patterns could be “drawn” with a micropipette, as well as 
imprinted with a PDMS stamp.124 
Other than monomeric catecholic initiators for SI-ATRP, reviewed elsewhere in this paper, 
Zhou et al. reported on a polymeric macroinitiator for SI-ATRP, bearing dopamine groups for 
surface anchoring and reactive groups intended for growing functional polymeric brushes, like 
temperature-sensitive poly(N-isopropyl acrylamide). According to the authors, polymeric 
initiators provide stronger interactions with surfaces and higher stability than small- molecule 
initiators studied so far.125 
Using a biomimetic approach, Payne and co-workers focused their investigations on the 
enzyme-assisted cross-linking of chitosan with phenols, in which o-quinone electrophilic 
intermediates were likely formed by the oxidative reaction of tyrosinase, either with phenolic 
residues in proteins –as a versatile strategy to cross-link proteins and polysaccharides-, or with 
added phenols intended as cross-linking moieties. In the first case, it was possible to conjugate 
untagged and hystidine-tagged organophosphorous hydrolase, cytochrome C and an 
acetyltransferase to chitosan.[126] When gelatin was used, the resulting material was found to 
have gel-like properties.[ 127 ] Chitosan was also cross-linked with several phenols and 
polyphenols (including catechol and catechin) electrochemically, on top of a silicon wafer 
micropatterned with gold, acting as electrode. The micropatterned cross-linked films were 
flexible and mechanically stronger than the parent chitosan film. Micropatterning could be 
controlled over large surfaces with a resolution down to 20 m.[128]  
  
3. Macroscopic surface functionalization. 
 
3.1. Antifouling coatings. 
Messersmith and co-workers reported a water-soluble polymer made of three alternating 
units of DOPA and lysine attached to a 20-unit N-methoxyethylglycine antifouling peptoid. The 
anchoring (DOPA-Lys)3 end, a simplified mimic of the structure of mussel adhesive protein 
Mefp-5, was shown to provide strong adhesion of the polymer to titanium surfaces by means 
of a simple immersion procedure. The antifouling peptoid moiety conferred long-term 
resistance to the attachment of human serum proteins and cultured cell fibroblasts to the 
coated surface.[129] Similar polymers, but using only one, two or three DOPA units as anchor 
moieties for PEG, also showed resistance to serum protein adsorption on TiO2 surfaces. Fouling 
resistance was found to correlate with the number of co-joined DOPA residues at the anchor-
end, with PEG-DOPA3 affording the highest packing density.
[130] In a follow-up study, the 
performance of PEG-DOPA3 on TiO2 with regard to fouling resistance against certain species of 
diatom and green algae was found at least equal to, or better than that of a commercial 
polydimethylsiloxane (PDMS)-based coatings.[131] The same research group reported the first 
use of a catecholic initiator in a surface-initiated (SI) atom transfer radical polymerization 
(ATRP). The dopamine-based initiator was first anchored to a Ti surface, and subsequently 
reacted with OEG methacrylate, to yield brush-like, OEG-terminated antifouling coatings up to 
100 nm thick. By using standard photo-mask lithography, Ti surfaces were further patterned 
into coated (antifouling) and uncoated (cell-adhesive) areas, opening up the possibility of using 
these surfaces for cell array design.[132]  
In another biomimetic approach, Gademann and co-workers prepared a series of synthetic 
analogs of the catecholic chromophore moiety of siderophore anachelin, and conjugated them 
with PEG. An interesting feature of the catecholic anchor employed was the presence of a 
quaternized amino group, which made the anchor resistant to oxidation, as opposed to 
dopamine-based moieties. Furthermore, the positive charge on the anchor was suggested to 
increase its affinity to negatively-charged surfaces. Polymer coatings on glass and TiO2 surfaces 
were found resistant to cell and protein fouling, and could be made thicker than dopamine-
based ones.[133] Dopamine-based anchors amenable through simpler synthetic procedures 
were also prepared. Among these, an anchor featuring a quaternized amine afforded the 
polymer adlayer with highest packing density, with antifouling properties comparable to those 
of a similar polymer with two non-quaternized dopamine-based anchors.[134] Further research 
on anachelin-anchored polymers involved functionalization of the PEG end with antibiotic 
vancomycin, which added strong antimicrobial activity to the coating.[135,136]  
In addition to catechol-ended PEG polymers, diverse polymeric backbones with grafted 
catecholic moieties have been studied. Zürcher and co-workers grafted PEG and 3,4-
dihydroxyphenylacetic acid to a polylysine backbone. The polymer self-assembled 
spontaneously and electrostatically-driven on TiO2, showing excellent antifouling resistance. 
This was preserved even in strong electrolyte media, even though the rest of the polymer 
desorbed because of the electrostatic screening effect of the electrolytes. By comparison, a 
similar polymer to which only PEG was grafted, quickly desorbed in the same conditions, 
proving that the role of surface-independent adhesion of the catecholic moieties is 
essential.[137] Because of the presence of multiple anchoring units distributed along the 
polymer backbone, the graft-to approach was employed successfully in widening the scope of 
surfaces and materials (metals, oxides, PTFE) to which PEG-modified polymers could be 
robustly attached, without impairment of the surface-modifying capabilities and the high 
resistance to fouling by protein and cell adhesion of PEG-ylated polymers.[138] 
A third architectural strategy, involving the use of dendritic PEG polymers, was reported 
recently by Textor and co-workers. PEG dendrimers were covalently attached to anchors based 
on assemblages of one or two- or three-covalently bound catechol groups. When at least three 
catechol groups were present, the dendrons attached fast and irreversibly to TiO2 surfaces as 
monolayers with persistent antifouling properties. Despite presenting lower levels of hydration 
in aqueous media, dendritic PEGs conferred antifouling properties comparable to those of 
linear-PEG groups. Furthermore, they afforded denser packings at lower temperatures and 
electrolyte concentrations.[139] 
Finally, a multifunctional coating was prepared in which the antifouling monomer was able to 
immobilize specific biomarkers at the same time. Polymer brushes with anchoring DOPA units 
at one end and carboxybetaine on the other side were grown on gold surfaces. In addition to 
exhibiting excellent anti-fouling properties, antibodies of an activated leukocyte cell adhesion 
molecule (ALCAM) were successfully immobilized on this coating, giving rise to detectable 
surface plasmon resonance signals when the surface was exposed to biological media 
containing this cancer biomarker (ALCAM).[140] 
 
3.2. Antibacterial coatings. 
Detrembleur and co-workers have recently reported on two different antibacterial coatings 
assembled on stainless steel surfaces using a layer-by-layer approach. Antimicrobial films were 
fabricated, consisting of alternating layers of a polycationic copolymer with pendant units of 
DOPA and a quaternary ammonium salt, and an anionic polystyrene sulfonate, either flat-
layered [141] or arranged in layers of micelles.142 DOPA units in the bottom layer ensured good 
adhesion to stainless steel surfaces. On top of it, the middle layers of the polycationic 
copolymer were placed in contact with an Ag+ solution, which induced the partial precipitation 
of nanoparticulate Ag, so that elemental Ag, Ag+ and precipitated AgCl ended up embedded in 
the film, providing antibacterial activity. Even after depletion of the Ag, the polycationic layers 
provided residual antimicrobial activity, which could be reactivated by immersion of the 
coated surface in a AgNO3 solution.
 In a second study, the same polycationic copolymer was 
used as a bottom layer, while the middle section was replaced by layers of oxidized (fully-
quinoid) DOPA-polymethacrylate and polyallylamine (PAA), alternatively laid on top of each 
other. It was found that the amine residues of PAA reacted with the quinone residues in the 
other polymer, thereby cross-linking the successive layers with each other. For the top five 
layers, oligopeptide nisin -known for its anti-Gram positive antibacterial properties and non-
toxicity- substituted for PAA. Despite its complexity, the coating was assembled on stainless 
steel without oxidizing agents and in mild, aqueous conditions in only 1h, and showed strong 
antibacterial activity after 24h.[143] Using a simple strategy, Rahimipour and co-workers 
recently coated a variety of substrates with polydopamine and further reacted the adlayer 
with low-toxicity agent - a modified ultrashort lipopeptide with antibacterial activity-. The 
coating was shown to be robust and effective against E. coli.144 
In addition to anchoring and antibacterial moieties, the incorporation of a third functional unit 
in the polymer may afford the adjustment of critical physico-chemical parameters. In a recent 
report, a terpolymer of dopamine-metacrylate, a long-chain-alkyldimethylethyloxyammonium 
metacrylate (biocide) and methoxyethylmetacrylate (hydrophobic/hydrophilic fine-tuner) was 
prepared. This polymer was shown to be tunable to a wide variety of polarities, which should 
allow the optimization of antimicrobial activity.[145]  
Using a simple approach, Xu, Mao et al., rendered cotton fabric antimicrobial by coating with 
polydopamine and subsequent deposition Ag nanoparticles by in situ reduction of Ag+. The 
fabrics showed strong antibacterial activity after 30 washes.[146] In an elaborate example of 
multifunctionality, Xu and co-workers attached dehydrocaffeic acid (DHDCA) to TiO2 
nanoparticles, to which Ag nanoparticles had been previously grafted. TiO2-Ag modified 
nanoconjugates were then treated with DMDHEU -an anti-wrinkle agent for cotton fabrics-. 
Cotton samples dipped in an aqueous suspension of this DMDHEU-DHDCA modified TiO2-Ag 
nanoconjugates, once dried and over-cured, achieved a high-grade durable-press rating, while 
showing as well antibacterial properties.[147] Following a similar strategy on a different 
substrate, C.K. Lee et al. obtained an antibacterial nanocomposite of bacterial cellulose, 
polydopamine, magnetite NPs, and precipitated Ag NPs.[148] 
Research on suitable coatings that selectively inhibit bacterial adhesion but at the same time 
promote the growth of beneficial host cells was reported by Neoh and co-workers. In an early 
study, dopamine was used as an anchor moiety for tripeptide- and collagen-based coatings. It 
was shown that immobilized collagen promoted the adhesion of both fibroblast and 
Staphyloccocus aureus, whereas the immobilized RGD tripeptide sequence promoted 
fibroblast adhesion without any apparent effect on E. coli or S. aureus adhesion.[149] More 
recently, this group reported the functionalization of two antibacterial polysaccharides -
carboxymethylchitosan and hyaluronic acid-, using dopamine as anchoring points, and vascular 
endothelial growth factor (VEGF) as promoter of osteoblast formation. Test results indicated 
that osteoblast growth was favored by this multifunctional coating, which concomitantly 
inhibited the adhesion of Staphylococcus aureus. [150] 
In their continuing investigation of antifouling DOPA-polycarboxybetaine coatings, Jiang and 
co-workers successfully added biosensing capabilities to gold[140] and SiO2
[ 151 ] surfaces. 
Antibodies of an activated leukocyte cell adhesion molecule (ALCAM) were immobilized on the 
polymeric coating, giving rise to detectable surface plasmon resonance signals when the 
modified surface was exposed to biological media containing this cancer biomarker (ALCAM), 
while at the same time showing excellent resistance to protein fouling in 100% human plasma 
and serum. This multifunctional approach was said to overcome non-specific protein uptake, 
which often severely limits the use of biosensors in biological media.[151] 
 
3.3. Anti-corrosion & anti-wear coatings. 
An early report by Waite and co-workers presented model corrosion studies showing that 
mussel foot protein is a good corrosion inhibitor of stainless steel, as compared with bovine 
albumin, 3,4-dihydroxybenzoic acid and polylysine. Interestingly, a synthetic analog of the mfp 
not only did not inhibit corrosion, but enhanced it. It was suggested that the secondary 
structure of the natural mfp might be playing a significant role in the inhibition mechanism.[152] 
In a more recent attempt to confer corrosion resistance to metal surfaces, Yang et al. 
functionalized aluminum surfaces with a mercaptopropyl-terminated silane, which was in turn 
reacted with dopamine. Finally, dopamine moieties were covalently linked to tetradecyl 
pendant groups. Whereas a bilayer of siloxane-dopamine already enhanced the corrosion 
resistance of the material by 2 orders or magnitude in saline solutions, once completed with a 
hydrophobic layer on top, this resistance was roughly three orders of magnitude higher than 
that of bare Al. Nevertheless, the anticorrosion resistance in test conditions decreased sharply 
after two days, likely due to the loss of some tetradecyl side chains and exposure of the 
hydrophilic dopamine coating.[153] Using a different approach, Detrembleur et al. studied the 
LbL deposition on galvanized steel of clay and a policationic copolymer of dopamine and an 
alkyl quaternary ammonium salt. This assemblage provided an effective barrier against 
corrosion that avoided the use of toxic chromic treatments.154  
In order to explore the usefulness of dopamine in anti-wear applications, Zhou and co-workers 
used it as an anchor on Si surfaces for an imidazolium-based ionic liquid. The authors showed 
that the wetting of the modified surface could be tailored by choice of an appropriate counter-
ion. On the other hand, the tribological properties of a Si surface directly spin-coated with the 
ionic liquid, a second surface coated with a dopamine-ionic liquid SAM, and a third one in 
which the imidazolium-based ionic liquid was spin-coated on top of a dopamine-ionic liquid 
SAM were compared. It was shown that while both the bare SAM and the surface directly spin-
coated with the ionic liquid presented significant wear, the composite coating performed 
much better in terms of both wear resistance and load-carrying capacity.[155] In a different 
study aimed at the development of novel water-based lubricants, the same authors reported 
the coating of PTFE powder with polydopamine. In addition to water dispersibility, the 
performance of a 0.8% w/v water suspension of the dopamine-modified PTFE powder as 
lubricant was compared with that of distilled water. For the suspension, the friction coefficient 
remained stable at ca. 0.1 after 30', whereas that of water increased dramatically within 5 
min.[156] 
 
3.4. Hydrophobic/hydrophilic coatings. 
Polydopamine offers a simple, generic and straightforward way to radically modify the surface 
energy of materials, either directly by making them hydrophilic or, alternatively, as a mediator 
coating for hydrophobic ad-layers. Chen et al. made a copper surface water-repellent by 
modification with polydopamine, followed by reaction of the ad-layer with dodecanethiol. In 
addition to hydrophobicity, the modified surface was found to be corrosion-resistant in saline 
media, likely because it limited the infiltration of Cl- anions.[157] Park, Choi and co-workers 
rendered porous polyethylene sheets hydrophilic with polydopamine, without affecting the 
degree of porosity of the substrate. This way, the material, intended for separators in Li-ion 
batteries, could be easily soaked with polar electrolyte fluids -e.g. propylene carbonate-, and 
used to prepare a model cell that showed improved electric performance, such as lower 
resistance and greater discharge current densities after repeated cycles.[158] The amphiphilic 
character of polydopamine films, which may be positively charged by protonation of the 
indolic nitrogen atoms or negatively charged by deprotonation of unoxidized catecholic 
hydroxyl groups, was put to use in the fabrication of permselective electrodes. Au-coated Si 
wafers, additionally coated with polydopamine, were found to selectively block cations at 
pH<3, and anions at pH>11. The pH-dependent permselectivity was shown to be fully 
reversible and was characterized by cyclic voltammetry using redox-active probes.[ 159 ] 
Polydopamine afforded as well an interesting combination of adhesion and 
superhydrophobicity on the same material. Lee and co-workers micro-patterned a 
superhydrophobic polyfluorosiloxane-coated anodic aluminum oxide surface with capillary 
channels of adhesive, hydrophilic polydopamine. Water droplets were shown to stick to the 
patterned surface, which was able to hold them, even when it was flipped upside down. At the 
same time, the patterned substrate still kept a high water/surface contact angle, typical of 
superhydrophobic surfaces. This material was used to fabricate a water capturing device 
reminiscent of the water-collection technique of the desert beetle.[160] A similar approach that  
combined polydopamine-coated hydrophilic micro-troughs patterned on superhydrophobic 
anodized aluminium oxide (AAO), was used by the same authors to devise a purely gravity-
driven microfluidics device for the channeling of aqueous droplets into chemical reactions  in 
the microscale. The high channeling efficiency of this pump-free mixing device afforded 
remarkably high reaction throughputs.161 
Hydrophobicity and superhydrophobicity on surfaces was also achieved by covalently linking 
perfluoroalkyl chains to catecholic anchors, or grafting fluorinated chains and catecholic 
anchors to polymer backbones, respectively. Spencer et al. coated TiO2 surfaces with SAMs of 
a perflouroalkylated derivative of 6-nitrodopamine. Surfaces showing water contact angles of 
up to 105º, plus time-dependent hydrophobic gradients could be achieved by controlling the 
exposure time of the surface to the coating solution. The use of the nitro derivative was judged 
essential, since its electron-withdrawing character ensured that catechol moieties wouldn’t 
oxidize easily and, accordingly, true catechol SAMs -instead of randomly cross-linked polymers- 
could be obtained. [162]  
Zhou and co-workers prepared catechol-anchored, grafted fluoropolymers using two different 
strategies. In one instance, a copolymer of DOPA-methacrylate and a perfluoroalkyl 
methacrylate was synthesized. This fluorinated polymer attached itself to a variety of surfaces 
(Ti, Al, Cu, Si, steel, glass, and organic polymers), which exhibited low surface energies and high 
water contact angles (ca. 120º) consistent with high hydrophobicity. When roughness was 
added to a surface of alumina in the form of nanowire forests, contact angles went up to 165º 
(superhydrophobicity).[163] In another study, the authors chose a catechol derivative both as 
anchor and activator for surface-initiated polymerization by ring-opening metathesis (ROMP) 
of a norbornene spacer with a perfluoroalkyl pendant group. The coating was successfully 
carried out on a variety of surfaces, such as TiO2 nanowires, Al2O3, Ag, Zn, and many others. As 
in the previous study, surface-modified Al2O3 nanowires showed superhydrophobic 
behavior.[ 164 ] The same research group reported on the use of polydopamine-coated 
mesoporous silica NPs as reservoirs for the controlled release of a hydrophobic molecule 
(octadecylamine). When substrates coated with these NPs were etched so as to remove the 
hydrophobic coating, underlying octadecylamine migrated to the surface and bound 
chemically to the polydopamine layer. Thus, the hydrophobic character of the surface was 
restored in 24 h in a self-healing fashion that could be cycle at least 25 times without apparent 
loss of surface properties. Moreover, thanks to the the rough microstructure of the surface, 
the coating afforded water repellency in the superhydrophobic range.165 
A couple of studies have been recently reported concerning the modification of surface 
properties with polydopamine in practical applications. Yin and co-workers coated the inner 
surface of an open-tubular capillary column intended for capillary electro-chromatography, 
and found that the electro-osmotic flow could be better controlled, compared to an uncoated 
column, thanks to the residual, basic hydroxyl and acid amino groups in the polymer. In 
addition, the polydopamine coating afforded an improved resolution in the separation of four 
auxines.[166]Hydrophilicity was conferred to hydrophobic polysulfone membranes intended for 
reverse osmosis by means of a plain polydopamine coating, resulting in a significant 
improvement in osmotic flux performance. The authors remarked that this approach –
hydrophilic coating of hydrophobic, tough polymers- should be advantageous in this 
application as opposed to the use of intrinsically hydrophilic polymers, which would be prone 
to swelling and plasticizing upon aqueous wetting.[167] 
  
4. Micro-/Nanoscopic surface functionalization. 
 
Iron oxide nanoparticles (NPs) have been researched extensively in recent years because they 
provide many potentially useful properties, such as superparamagnetism and cellular uptake, 
which are essential to MRI imaging and other biomedical applications. For magnetic NPs to 
play a successful therapeutic role, they should be stable and homogeneously dispersed in 
biological fluids, not readily recognized and disposed of by the immune system, and be 
efficiently directed to, and internalized by specific targets.[168] Since catechol derivatives are 
efficient chelators of ferric ions, they constitute a natural choice as robust surface anchors for 
magnetic NPs. Particularly, dopamine offers, in addition to a catechol moiety, a functional end-
group amenable to cost effective derivatization procedures.[169] 
 Although relevant non-biomedical applications have been explored,[ 170 , 171 , 172 ] catechol-
modified ferric NPs were intended in most cases for biomedical applications in which the 
magnetic properties of the NP core are themselves useful for MRI imaging,[173,174,175,176,177,178] or 
else NPs act as carriers for therapeutic payloads, either to scavenge pollutants in body 
fluids,[179] or to be selectively uptaken by diseased cells.[180,181,182,183,184] Since dopamine may be 
functionalized in an easy, straightforward fashion, it has been the anchor moiety of choice for 
the majority of these studies, although DOPA,[174,181] nitroDOPA,[173,184, 185 ] and 
dihydroxybenzylamine,[186] among other catechol derivatives, have also been used to this 
effect. Conjugated to the catecholic anchor, PEG was chosen almost exclusively as 
biocompatible stabilizer of NPs in physiological media, in addition a few others, such as 
hyaluronic acid,[177] oligopeptidic chains[171] and poly(carboxybetaine methacrylate).[174] In 
several cases, extra functional moieties, such as specific chelating agents,[170,178,179,186] 
porphyrin,[180] and therapeutic drug moieties,[182,183] were covalently linked at the end of the 
PEG chain or directly conjugated to the anchor. In addition to the bibliography commented in 
this Section, a very recent review on the role catechol derivatives in iron oxide NP 
functionalization should provide the reader with additional details on this topic.187 
 
4.1. Colloid stabilization. 
In an early report, Sun and co-workers coated Fe3O4 nanoparticles with a PEG-triazine-
dopamine conjugate, which afforded a convenient synthetic route to link together PEG chains 
and dopamine anchors. The stability of nanoparticle dispersions in aqueous buffered media 
with high saline concentration was satisfactory.[169] In a follow-up study, 9-nm NPs were 
functionalized with PEG-dopamine, but in this case standard EDC/NHS coupling chemistry was 
used instead in order to conjugate PEG and dopamine moieties. The functionalized NPs didn't 
aggregate after a 24h period of incubation in PBS solutions and showed decreased uptake by 
macrophage cells, which suggested that they would escape the immune system in potential 
biomedical applications.[175] 
Reinhult and co-workers coated Fe3O4 nanoparticles (30 nm) with nine different PEG-based 
dispersants and found that nitroDOPA and nitrodopamine anchors afforded the highest 
colloidal stability in physiological media even at high temperatures and dilutions.[173] The same 
authors investigated the effect of the ring pendant groups on the bonding affinity of several 
catechol anchors. It was found that substituted nitrocatechols bind to FeII sites, which transfer 
one electron that ends up delocalized in the nitroaryl moiety. These complexes were found to 
be stable, oxidation resistant, and could be formed at lower pHs, thanks to the lower pKa of 
nitrocatechols, compared to that of (pyro)catechol. On the other hand, complexation of FeIII by 
nitrocatechols was very poor. With regard to catechol derivatives without electron-
withdrawing groups, it was shown that they efficiently bind to FeIII atoms, but eventually 
degrade by oxidation of the catecholic moiety, leading to poor final stabilization. Finally, 
mimosin, a catechol-semiquinone analog, was shown to have such a high affinity toward the 
NPs that it led to their incipient dissolution.[185] The stability (> 1d) of iron oxide NPs 
functionalized with dopamine anchors was also investigated by Carpenter et al. It was 
concluded that despite their good initial dispersibility in aqueous media, NPs eventually 
degrade because of oxidation of the dopamine moieties by FeIII ions on the NP surface. The 
authors provide a tentative step-wise mechanism explaining the eventual detachment of the 
oxidized dopamine layer and concomitant precipitation of the NPs.188 
In order to gain insight on the NP aggregation process, Fe3O4 nanoparticles were coated with 
random copolymer brushes of 2-(2-methoxyethoxy) ethyl methacrylate and oligo(ethylene 
glycol) methacrylate, with molar fractions of 90% and 10%, respectively, anchored to the 
surface through dopamine end-caps. The authors showed that nanoparticles had robust 
colloidal stability and excellent biocompatibility. Plus, the aggregation-disaggregation of the 
NPs was reversible and adjustable by temperature control.[189,190,191] In a further study, it was 
shown that nanoparticles thus functionalized had a good balance of interchangeable 
hydrophobic and hydrophilic characters that might explain their ability to cross cell 
membranes.[192] 
Simard and co-workers focused on the protection of pure Fe NPs using a core-shell 
methodology, in order to obtain nanoparticles with higher magnetization values than those of 
FexOy. A multi-layer approach was used, where a magnetic Fe core was subsequently coated 
with different metal and metal-oxide shells. In the case of NPs with an exterior crystalline 
FexOy shell, the last coatings applied were dopamine and dopamine-PEG. Coated nanoparticles 
showed near-monodispersivity and excellent stability in aqueous media at different pHs, and 
kept their superparamagnetic behavior at least up to 1 yr. Magnetization values were in 
accordance with the Fe nucleus/FexOy coating ratio, making them superior in this respect to 
other particles with non-magnetic (for instance, Au) protective coatings.[176] 
 
4.2. Therapeutic uses and imaging. 
One of the first reports on the functionalization of Fe3O4 nanoparticles for potential 
therapeutic uses was published by Xu and co-workers. NPs were coated with a ligand featuring 
dopamine as an anchor and a terminal porphyrin. The authors suggested that the 
simultaneous presence of superparamagnetic magnetite cores and porphyrin ends in the same 
particles was intended as a double strategy for cancer therapy, since both moieties are 
potentially therapeutic for hyperthermia and photodynamic cancer therapy, respectively. 
Modified nanoparticles were able to penetrate the cytoplasm of HeLa cells and induce 
apoptosis upon irradiation with light of a suitable wavelength.[180] The same research group 
later reported on the design of coated NPs in which functional moieties were located in the NP 
core, as opposed to the more usual approach by which they are linked to the surface coating. 
‘Yolk-shell’ FePt nanoparticles were thus prepared, where FePt NPs were coated with porous 
shells of iron oxide. NPs were finally surface-modified with L-DOPA for adequate dispersion in 
aqueous media. In this case, the functional payload consisted of highly cytotoxic Pt ions 
released from the FePt core once this started to oxidize, and the Pt ions then squeezed 
through the Fe2O3 shell. The NPs were shown to be superparamagnetic and suitable for MRI 
detection. With regard to therapeutic activity, the NPs turned out cytotoxic against HeLa cells, 
the IC50 values in terms of Pt mass per unit volume being comparable to those of cis-platin.
[181]  
Messersmith and co-workers reported the coating of Fe3O4 nanoparticles with dopamine-
functionalized hyaluronic acid. The coating was effective in ensuring good dispersion of the 
NPs in aqueous media for at least 4 days, after which the quality of the dispersion was found 
to correlate with the degree of dopamine conjugation. The usefulness of the surface-modified 
NPs in cancer therapy was tested by studying by MRI the preferential uptake of the NPs by 
strains of cancerous cells having over-expressed hyaluronic acid receptors. Blank experiments 
without dopamine showed a low degree of uptake, proving the essential role of the robust 
catecholic anchorage. On the other hand, hyaluronic acid played a double role, both as NP 
stabilizer and target moiety.[177] Another selective therapeutic approach was reported by Sun 
et al., using 4-methylcatechol as anchor for the iron oxide NPs. A subsequent Mannich reaction 
of the catechol with formaldehyde and an oligopeptide afforded functionalized NP that were 
shown stable in aqueous suspension for long times and able to target tumor cells in vivo, 
showing specificity for the target molecule expressed by the tumor cells and little uptake by 
the immune system.[182] 
Jiang and co-workers coated Fe3O4 NPs with a DOPA2-grafted polycarboxybetaine metacrylate. 
The magnetic NPs showed long term stability in physiological conditions and lower 
macrophage uptake compared with dextran-coated NPs. When the coated NPs were further 
functionalized with a suitable target peptide, they showed enhanced uptake by human 
umbilical vein endothelial cells, as visualized by MRI.[174] 
Labeling of nanoparticles with lanthanides for biomedical applications has been reported 
recently. Park and co-workers functionalized Fe3O4 NPs with both DOPA-anchored PEG chains 
–in order to provide aqueous stability- and functional chains, consisting of dopamine anchors 
covalently linked to a specific chelating agent for GdIII. The resulting Gd-labeled magnetite 
nanoparticles were intended for use as high resolution dual (T1- and T2-weighted) MRI contrast 
agents. Their performance in vivo showed the enhanced accuracy provided by the dual 
detection. The authors remarked that the superparamagnetic character of magnetite was not 
altered significantly upon surface modification.[178] Yang et al. prepared two different 
luminescent TbIII-labeled nanoparticles based on sensitization of an organic fluorescent 
chromophore. The TbIII ligand holds the chromophore on one end and a dopamine anchor on 
the other. It was estimated that about 2000 Tb cations were associated to each magnetite NP 
this way. The NPs showed low cytotoxicity, high uptake capacity by HeLa cells and 
simultaneous superparamegnetic behavior and strong fluorescence needed for dual 
MRI/fluorescence cell imaging.[186] 
Xu and co-workers reported a general methodology for the preparation of nanoparticulate 
heterodimers with sizes below 20 nm. The authors showed that each half of the dimer could 
be functionalized separately owing to the different surface characteristics of the substrate 
particles and the respective affinities of the ligands to the substrates. The ability to fabricate 
multifunctional heterodimers was exemplified by fabricating a Fe3O4-Ag nanoparticulate 
assembly, and subsequently attaching a dopamine-anchored biotin to the Fe3O4 half, and a 
thiolated porphyrin to the Ag moiety.[193] In a follow-up investigation, the same authors 
prepared dumbbell-like heterodimers of Fe3O4-Au nanoparticles with core diameters of 20 & 8 
nm, respectively. To the magnetite moiety, epidermal growth factor receptor (EGFR) antibody 
was attached via PEG, using dopamine as an anchor. On the other side, the Au NP was 
protected with HS-PEG-NH2. Dumbbells were stable against aggregation in biological media, 
showed superparamagnetic behavior on account of the Fe3O4 moiety, and exhibited surface-
plasmonic absorption thanks to the Au moiety. A431 cells known to over-express the EGFR 
showed selective absorption of the NPs. This was detected by reflectance at the appropriate 
wavelength using confocal microscopy, which resulted in stable images even after 6 days. This 
was considered particularly important, since it would allow long-term tracking of the NPs in 
cell cultures, as opposed to fluorescent tags, for which signal loss is usually very fast.[194] 
Recently, Mattoussi and co-workers reported the PEG-functionalization of iron oxide NPs with 
a novel polymer bearing multiple dopamine moieties. The use of such multidentate anchors 
afforded a much higher colloidal stability of the NPs, especially across a broad range of pH and 
electrolyte concentrations, as compared with the usual approach consisting of single anchored 
functional moieties. The modified NPs showed no relevant cytotoxicity, could be used as MRI 
contrast agents, and were amenable to the incorporation of additional functionalities through 
appropriate chemical modification of PEG chains.195 
4.3. (Bio)sensors. 
In one of the first studies showcasing catechol-as-anchor functionalization of NPs, Xu and co-
workers reported the synthesis of a composite material comprising magnetic nanoparticles 
(Fe2O3, SmCo5), dopamine as anchor moiety for a nitrilotriacetic acid-Ni
2+ complex, intended as 
a selective chelating agent for hystidine-tagged proteins. It was shown that this ensemble is 
able to bind the proteins of interest with higher selectivity than a commercial affinity column. 
The functionalized nanoparticles were stable, and could be regenerated and reused for the 
separation purposes mentioned.[196] 
More recently, Yang, Sun and co-workers reported that rhodamine 6G (Rh6G) coupled to PEG-
dopamine-modified Fe3O4 nanoparticles could be used as an Fe
III-selective fluorescent sensor. 
It was further shown that functionalized NPs may detect FeIII inside cells, by incubation of HeLa 
cells in FeIII-containing biological media and final uptake of the NPs. A strong red fluorescence 
was observed in the FeIII-incubated cells, but not in the control batch.[197] 
An early report by Rajh and co-workers on DNA recognition described the preparation of 
triadic systems comprising TiO2 nanoparticles, dopamine anchors and DNA oligonucleotides. 
With DNA sequences having the proper oxidation potential and upon the action of light, 
electrons could be transferred from the DNA strand to the dopamine-TiO2 dyad, thanks to the 
efficient electronic coupling of the dopamine anchor to the TiO2 surface. The charge separation 
was so extended that resulting charges did not recombine and were, thus, available for redox 
reactions at both (DNA/TiO2) ends of the system. Importantly, the redox properties of the triad 
were found dependent on the oligonucleotide sequence of the DNA, as well as on the extent 
of mismatch between NP-bound DNA strands and complementary "sensed" strands to which it 
hybridized.[198] In a follow-up investigation, it was found that upon the action of light, electrons 
were transferred from DNA to the dopamine-TiO2 dyad, whereas holes were transferred 
selectively to guanine bases. The efficiency of the charge separation was dependent upon the 
distance of the first guanine base (hole trap) and the existence of adenine bases (hopping 
sites). This effect was studied photochemically, and also by observing the amount of Ag 
deposited by the photochemically induced electron transfer to the electrode: The more 
efficient the ET, the higher the amount of charge transferred to the Ag+ solution and thus the 
greater the amount of Ag precipitated.[199] 
Recently, Park et al. reported the use of dopamine-anchored fluorescein-grafted hyaluronic 
acid to gold nanoparticles as fluorescent labels. Upon incubation of the NPs in test media 
where reactive oxygen species (ROS) were being generated, hyaluronic acid degraded, 
eventually liberating the fluorescein moiety and thus increasing the overall fluorescence, 
which stayed low for as long as the polymer chains remained attached to the gold NPs 
(quencher). These fluorescent-tagged NPs were suggested as real-time markers for ROS, with a 
fluorescent signal higher than that of commercial fluorescent probes for both chemically- and 
intracellular-generated ROS.[200] 
Wang et al. reported coating magnetite NPs with polydopamine, on which Au NPs were later 
grown. This nanocomposite material was used to make an electrochemical sensor for 
hemoglobin and interleukin-6.[201] In two separate studies, molecular imprinting analysis of 
proteins was explored by coating iron oxide NPs with polydopamine in the presence of 
myoglobin, horse-radish peroxidase,[202] and bovine hemoglobin.[203] The imprinted coating was 
shown to recognize the template proteins with acceptable selectivity. Furthermore, the 
adsorbed proteins could be easily isolated from the solution by using a magnet.[203] In another 
study, Zhang and co-workers prepared polydopamine-coated carboxyl-functionalized 
magnetite NPs for protein recognition.204 
4.4. Miscellaneous NP functionalization. 
A few studies have recently focused on controlled release of active species involving catecholic 
moieties. Sun and co-workers coupled 6-hydroxy-chromone-3-carbaldehyde -used as a model 
drug with antifungal, antiviral, antihypertensive, and anticancer activity-, to PEG-dopamine-
Fe3O4 nanoparticles via Schiff-base chemistry. This way, the drug could be set free by 
adjustment of the pH by hydrolysis of the Schiff-base bond, indicating that these NP 
conjugates may be thought of as control-release systems in acidic environments. In vitro tests 
showed that drug conjugates were soluble in the biological culture medium and readily 
absorbed by HeLa cells, were they presented a high level of cytotoxicity.[183] An interesting 
architectural strategy involving magnetic NPs and controlled release was reported by Reinhult 
and co-workers. The use of coatings based on hydrophobic chains, instead of PEG, afforded 
palmityl-nitroDOPA-coated NPs able to spontaneously associate with a specific phospholipid 
capable of forming micelles. One self-assembled, the liposomes were shown to carry the NPs 
embedded in the lipidic bilayer. This structure was responsive to the application alternating 
magnetic fields, which upon heating the NPs, prompted the dissociation of the lipidic wall and 
the release of a proof-of-concept cargo -a fluorescent probe-.[184] 
Fe3O4 NPs were used as controllable nano-scavengers using dopamine-anchored 
bis(phosphonate) groups to scavenge uranyl cations from water and blood samples. Uranyl 
removal was reported to be quantitative in contaminated water samples, and as high as 69% in 
blood samples where phosphate ion in solution and proteins compete for uranyl coordination. 
After complexation, nanoparticles were easily removed from the medium with a magnet. As of 
the publication date, this was the first reported example of removal of radionuclides from 
biological fluids using nanoparticles.[179] 
Catecholic anchors have allowed the incorporation of iron oxide nanoparticles into complex 
frameworks and the adoption of sophisticated coating methodologies. Tremel and co-workers 
reported coating Fe2O3 nanocrystals with SiO2 shells using an enzymatic strategy. NPs were 
coated with a polymer containing a dopamine anchor at one end, and a nitrilotriacetic acid 
moiety at the other, the latter capable of binding NiII. In a second stage, NiII cations were 
bound to the surface of the coated NPs. The coordination sphere of the NiII centers was then 
completed with hystidine moieties via coordination by a hystidine-tagged silicatein. Finally, 
upon addition of tetraethoxysilane to a dispersion of the modified nanoparticles, silicatein 
catalyzed the formation of a silica crust around them.[170] Xu et al. prepared a magneto-
rheological hydrogel as a composite material fabricated by mixing a conjugate of 2-
(naphthalen-2-yl) acetic acid with Phe(nylalanine)–Phe(nylalanine) and Fe3O4 nanoparticles 
surface-functionalized with a Phe-Phe-catechol conjugate. The first molecule was able to form 
a hydrogel by itself, which on mixing with the functionalized magnetite NPs, spontaneously 
incorporated them into a nanofiber network. Upon application of even small magnetic fields, 
the hydrogel became liquid and the nanoparticles precipitated out. Heating/cooling cycles 
were able to reversibly regenerate the hydrogel.[171] Catecholic anchors also facilitated the 
incorporation of liquid crystals and magnetic NPs in polymeric matrices. A polysiloxane 
backbone copolymerized with dopamine metacrylate and nematic liquid crystal mesogens was 
further reacted with ferrite nanoparticles, which end up attached to the polymer through the 
catecholic pendant groups. 1 m-thick films of the Fe3O4-modified polymer on Indium-doped 
tin oxide (ITO) surfaces were shown to be transparent in the visible range. The degree of 
transparency, directly related to the phase order, could be tuned by the application of a 
magnetic field.[172] 
With the exception of DSSC-related applications (Section 8.2), and quantum dots (Section 8.3) 
a brief review of the functionalization of non-ferric NPs intended for use in materials 
applications will follow.  
Studart and co-workers prepared coatings for Al2O3 nanoparticles that were highly efficient 
against self-aggregation by depositing a layer of gallol-PEG brushes of tailored length onto 65-
nm alumina nanoparticles, making it possible to obtain aqueous suspensions of the 
nanoparticles of up to 40& w/v.[205] Carbon nanotubes coated with polydopamine were thus 
made water-dispersible and functionalizable, for example, by reductive precipitation of Au NPs 
from a solution of HAuCl4. The polydopamine coating did not alter the morphology of the 
nanotube walls.[206] Protonated dopamine was used as both anchor and surface modifier for 
NPs employed in cathodic electrophoretic deposition (EPD) methods used to fabricate 
supercapacitors. MnO2 nanoparticles and multi-walled carbon nanotubes (MWCNTs) thus 
coated were found effective to obtain stable suspensions. Different binding mechanisms for 
the anchors were presumed: ligand-metal coordination for MnO2; -  stacking for the 
MWCNTs.[207] A similar strategy was applied to coat ZnO and TiO2 NPs for the electrophoretic 
deposition of these in composite films.[208] 
Messersmith and co-workers reported a method to anchor polymethylmetacrylate chains to a 
TiO2 surface, using a dopamine derivative both as anchoring moiety and initiator for SI-ATRP 
polymerization. The brominated dopamine derivative was first attached to the TiO2 surface 
and polymeric PMMA chains were later grown on the anchor. Because of the anchoring 
abilities of dopamine to a variety of substrates, this method was intended as a general-
purpose way of functionalizing all kinds of surfaces by ATRP.[209] 
In their study of nitrilotriacetic acid (NTA)-based chelating agents, Tremel and co-workers 
prepared a dual-anchor polymeric backbone functionalized with grafted NTA and dopamine 
pendant groups. NTA anchors were specifically chosen to partially coordinate Ni; the rest of 
the coordination sphere of this atom was then coordinated to surface S atoms forming part of 
the external layer of MoS2 nanoparticles or nanowires (termed, respectively, inorganic 
fullerenes and nanotubes). As opposed to unmodified MoS2, coated MoS2 NPs were soluble in 
polar solvents. Finally, through the available catecholic anchors, coated MoS2 NPs were 
attached to TiO2 nanorods, opening up the possibility to synthesize hybrid systems containing 
MoS2 nanoparticles and surfaces with other functional properties.
[210] 
TiO2 nanorods could be organized into liquid crystal phases after modification of the insoluble 
nanorods by means of a block copolymer comprising catecholic anchoring blocks and two 
different metacrylate esters as soluble blocks. Once functionalized, the nanorods were soluble 
and showed ability to pack densely together and form nematic and smectic mesophases, in 
which order was achieved by applying shear and meniscus forces.[211,212] When ZnO nanorod 
polymer hybrids with polystyrene soluble blocks were prepared, nanorod mesogens were 
observed to switch their preferential orientation under an applied AC electric field, from planar 
(parallel to the substrate) to homeotropic (perpendicular) in full analogy to the switching of 
low molecular weight liquid crystals inside an electric field.[213] 
A few studies describe catechol-based coated NPs in potential catalytic applications. As part of 
their investigation on surface modification of TiO2 nanoparticles with enediol ligands, 
Dimitrijevic et al. reported that 3,4-dihydroxyphenylacetic acid and dopamine coatings modify 
the electrochemical overpotential of hydrogen gas evolution on TiO2 nanoparticulate films.
[214] 
In a parallel study, Rajh and co-workers coated with dopamine TiO2 nanoparticles deposited on 
an ITO electrode. This coating was subsequently functionalized with biotin, to which avidin was 
complexed. The authors showed that avidin was able to accept photoinduced holes through 
the dopamine-biotin system, which led to dissociation of the biotin-avidin complex, probably 
because of the oxidation of the Tyr and Trp residues in avidin. This, in turn, led to a decrease in 
the photoinduced current intensity.215] 
The enhancement of polymer-filler interactions in composite materials is highly desirable in 
order to improve the mechanical properties of the polymer matrix, as exemplified by silica-
silane coupling in silica-filled elastomeric matrices.[216] Because of its affinity to a variety of 
inorganic substrates, catechol-based coatings offer an alternative to existent techniques for 
filler modification. Pan and co-workers reported the preparation of a co-styrene-butadiene 
(SBR) elastomer terminated with 3,4-dihydroxybenzaldehyde (DOBA). The catecholic end 
group was chosen because of its strong affinity to both hydrophobic carbon black and 
hydrophilic inorganic oxides (SiO2, TiO2), which constitute some the most widely used fillers for 
elastomeric materials. Compared with a reference unmodified SBR co-polymer, DOBA-
modified SBR showed a significant improvement in its mechanical properties, such as tensile 
strength, when reinforced with carbon black and TiO2. As far as viscoelastic properties are 
concerned, DOBA-modified SBR composites showed novel, interesting behavior.[217] Applying a 
complementary strategy, Lu et al. modified a clay filler with polydopamine. It was found that 
the strong interfacial interactions brought by the polydopamine benefited not only the 
dispersion of the D-clay in an epoxy resin, but also the effective interfacial stress transfer, 
leading to greatly improved thermomechanical properties at very low filler loadings.[218] In a 
similar fashion, Wang et al. rendered a carbon black filler hydrophilic and water dispersible by 
coating it with polydopamine.219 Taking advantage of the distinct chemical nature of each 
lamellar face in mineral kaolinite –with tetrahedral silicon oxide groups on one side, and 
octahedral aluminum oxide/hydroxide layers on the opposite-, Breu and co-workers were able 
to selectively functionalize aluminum faces with a hydrophobic catechol derivative, while 
substituting [Ru(bpy)3]
2+ for Na+ cations on the silicate-layered side. This way, the incipient 
Janus-like character of native kaolinite could be remarkably enhanced to afford, in this 
particular case, an amphiphilic variety of kaolinite.220 In another study by Bourmaud and co-
workers, polydopamine was used to treat polylactic acid in order to increase its compatibility 
with hemp fibers; these modified composites showed improved adhesion and mechanical 
properties.[221] 
Choi and co-workers reported the coating of single cells with a TiO2 shell of nanometer 
thickness, which was shown not impair cell viability significantly. Furthermore, the titania shell 
was amenable to functionalization via catechol chemistry, as exemplified by surface absorption 
of pyrocatechol violet dye.222 
  
5. Functional scaffolds. 
 
5.1. Oriental lacquers. 
Oriental lacquers (urushi) are manmade coatings of natural origin sourced from the cured sap 
of several trees native to Southeast Asia, -particularly, Rhus verniciflua-, that have been used 
for more than 2,000 years across the region to decorate objects with a flawless, high-gloss, 
polished finish. In addition to their highly artistic and cultural relevance, oriental lacquers have 
been studied for their useful qualities, such as being biodegradable, eco-friendly surface 
protectors,[223] with better solvent resistance compared to synthetic substitute lacquers, and 
excellent durability when stored in proper conditions.[224] Regarding its chemical composition, 
the sap of the lacquer tree is an o/w emulsion of several long-chain (C15, C17), 3- and 4- mono- 
and polyunsaturated alkylcatechols –collectively known as urushiol-, in an aqueous medium 
containing a complex mixture of polysaccharides, glycoproteins, metal ions and several 
enzymes with phenoloxidase activity, of which laccase is recognized as the most important 
one.[225] It is worth mentioning that urushiol-type alkylcatechols are not unique to lacquer 
trees; they are indeed secreted by several other plant species of the Anacardiaceae family, 
especially of the Toxicodendron genus, such as poison oak and poison ivy, where these 
chemicals are responsible for causing a notorious contact allergy.[226] Compared with poison 
ivy, urushiol, lacquer tree sap is richer in tris-unsaturated alkylcatechols, in which multiple 
insaturations facilitate aerobic polymerization reactions catalyzed by accompanying 
enzymes.[227] This polymerization reaction, which kills the allergenic activity of the urushiol 
monomers, is rather complex, involving several kinds of oxidative reactions, including direct 
ring-ring and ring-side chain double bond couplings, and side chain double bond oxidations 
and couplings. Although most new bonds are C-C, C-O bonds between linked units have been 
also observed.[224,228]  
The fabrication of a traditional urushiol lacquer is a slow and laborious process resembling 
covalent multilayer assembly,[229] which relies on the enzymatic curing action of laccase. 
Typically, the sap is applied to the surface as a solvent-less varnish, under controlled 
temperature and relative humidity conditions;[225] once dry, the lacquer layer is carefully 
polished prior to the application of next coating layer. Up to 30-40 layers of 5-10 m each are 
required for a quality lacquer coating.[227] Since the long overall duration of the traditional 
process is a major drawback, attempts have been made at developing alternative, more 
expedient curing methods,[230] without impairment of the visual qualities and eco-friendliness 
of traditionally-cured lacquers. Miyakoshi et al. reported that the addition of amino-
terminated silanes to urushiol yielded a fast curing urushiol-silane hybrid.[231] Hu and co-
workers found that extracted urushiol may be photo-cured in 2 min by irradiation with UV 
light, affording a wrinkled material.[232] Optimization of the irradiation conditions improved the 
finish quality of the UV-cured lacquer, which showed better chemical and solvent resistance 
than laccase-cured ones.[223] When urushiol was hydrogenated to almost quantitative 
saturation of the alkyl side chains, a sufficiently fast photopolymerization could be carried out 
while still obtaining glossy surfaces of sufficient quality to be usable for the restoration of 
lacquered antiques.[233]  
Lin et al. reported the polymerization of urushiols with UV light in the presence of transition 
metals, such as CuII. This improved the thermal stability of the lacquer by TG analysis, likely 
due to coordination between the catechol moieties and the metal center.[234] Urushiol 
composites with micro- and nanoparticles have been recently reported by the same authors. 
When urushiol was polymerized in the presence of AgI, the authors observed the precipitation 
of Ag microparticles and a sharp increase in the surface conductivity of the composite 
material.[ 235 ] Composite polyurushiol materials with homogeneously dispersed PbS 
nanorods,[236] and CdS nanoparticles,[237] were obtained by in situ UV-polymerization of 
urushiol/metal acetate mixtures and further exposure of urushiol-metal films to thioacetamide 
solutions. Urushiol was also used to coat silica nanoparticles by simple grafting of the 
catecholic moieties to the polar surface of the NPs,[238] and to prepare fluorescent coatings of a 
urushiol/bis-hydroxyquinoline-AlIII complex, by growing nanospheres of this material on glass 
using a “reverse” breath figure method.[239] 
Hybrid co-polymers of urushiol and polyurethane have been prepared by Cheong and co-
workers. Although the thermal stability of the copolymer slightly decreased with increasing 
urushiol content, the latter had a beneficial effect in corrosion tests and, especially, in showing 
antibacterial activity against S. aureus.[ 240 ] Multilayer films of polyurushiol (PU) and 
polyvinylpyrrolidone (PVP) were prepared by Weng et al. by alternatively dipping quartz and 
CaF2 substrates in solutions of PVP and urushiol, followed by UV-curing. AFM and hardness 
measurements indicated that UV-curing induced a certain degree of layer interpenetration.[241] 
When this process was carried out using urushiol/CuII solutions instead, PU/Cu microparticles 
embedded in PVP were observed to form on a pre-cured PU/PVP surface. Final treatment of 
the patterned substrates with a Na2S solution induced the growth of smaller CuS nanoparticles 
on the surface of the microparticles, yielding a superhydrophobic coating.[242] 
The natural polymerization process of urushiol has inspired Kobayashi and co-workers the 
synthesis of so-called “artificial urushi”, in which synthetic analogues of urushiol –both 
catechol- and phenol-based- were polymerized in mild aqueous conditions using laccase, to 
obtain hard, high-gloss films with excellent dynamo-mechanical properties.[199,243] This strategy 
was expanded to use iron(II)-N,N'-ethylenebis(salicylideneamine) as a substitute for a 
peroxidase enzyme in the “green” polymerization of alkylsubstituted phenols obtained from 
renewable sources.[199,244] A semi-synthetic analogue of urushiol was prepared by Lu, Zhang 
and co-workers by condensing natural urushiol, aniline and formaldehyde. The resulting 
thermosetting resin, an urushiol-based polybenzoxazine, showed excellent toughness, with 
lower tensile strength, but higher elongation at break than a typical polybenzoxazine, and 
comparable thermal resistance.245 
 
5.2. Melanin. 
Melanin is a generic term used to describe a variety of biopolymers found widespread in 
nature as pigments –including those found in hair, skin, eyes, feathers and Sepia ink-, derived 
from a common catecholic precursor -3,4-dihydroxyphenylalanine or DOPA- through a 
complex biosynthetic route known as melanogenesis.[246] The most widely studied type of 
melanin is dark-brown eumelanin,[247] recognized for its essential role as photoprotector.[248] 
Chemically speaking, eumelanin is a macromolecular structure formally constituted of 5,6-
dihydroxyindole (DHI) and 5,6-dihydroxyindolecarboxylic acid (DHICA) units in varying 
amounts,[247] linked together in potentially different configurations. The first stages of 
melanogenesis –i.e., those prior to polymerization- were already outlined by Raper,[249] and 
Mason,[250] and although later refined by subsequent investigations,[251] are still generically 
accepted. In essence, they involve a cascade of oxidation, reductive addition and 
tautomerization steps, some of them enzymatically controlled, featuring high-reactivity o-
quinones as electrophiles and oxidizers, and catecholic molecules as reducing species.[246] Even 
though extensive research has been carried out on their structure, melanins are among the 
few last biomacromolecular systems for which the organization of their constituent molecules, 
and its relation to precise biological functions, are still subject of debate, no less because of 
melanin’s notorious lack of solubility in all solvents, which makes its chemistry particularly 
challenging.[252,253,254]  On the other hand, melanins present a remarkably broad set of physico-
chemical properties, remarkable for their potential role as functional materials, such as anti-
oxidant and free radical scavenging behaviour,[255] broad-band monotonic absorption in the 
UV-Vis range, ultrafast thermal relaxation,[256] concomitant with extremely low radiative 
quantum yield,[ 257 ] and interesting electrical properties, such as reversible electrical 
switching,[258] and electrical conductivities typical of semiconductors, ranging from 10-5 to 10-13 
S·cm-1, which are strongly dependant on relative humidity.  
In the past years, significant advances have been done towards the elucidation of eumelanin 
structure. Indeed, the question of whether melanin is formed by high-molecular weight 
polymeric chains or aggregates of oligomers (protomolecules) is still not settled, although 
recent spectroscopic evidence seems to favor the latter theory.[259, 252] Watt and co-workers 
used low-voltage HRTEM to show that both synthetic and natural eumelanin consists of 
nanoaggregates of planar sheets of different sizes, separated by 3.7-4.0 Å spacings, typical of 
-  stackings in heteroaromatic systems. Moreover, the unique spectroscopic properties of 
melanin were found to be independent of aggregation, therefore indicating that they may be 
explained mostly by its primary structure.[252] This evidence seems to support a ‘chemical 
disorder’ hypothesis recently put forward by Meredith and co-workers,[260] according to which 
eumelanin would consist of a heterogeneous ensemble of chemically distinct chromophores, 
each with different photo-excitation energies. Individual chromophoric moieties would include 
colorless, reduced catecholic units (DHI, DHICA) and their respective colored oxidation 
products (indolequinones and related tautomeric forms), present in different proportions and 
linked together in different configurations. In addition to catechols and quinones, radical 
semiquinoid species in comproportionation equilibrium with these would be present in small 
amounts, accounting for the experimental observation of persistent ESR signals. The existence 
of stable amounts of quinones and quinoid radicals –which would otherwise be very short-
lived- in eumelanin may be justified by steric hindrance within the macromolecular 
scaffold.[253] Kaxiras and co-workers reported DFT in vacuo calculations on model cyclic, 
porphyrin-like, planar tetramers arising from all possible combinations of DHI, DHI-quinone 
and its tautomers -DHI-quinoneimine and DHI-quinone methide-. Results showed that hybrid 
cyclic frameworks containing both DHI-quinones and DHI moieties would have sufficiently low 
energy as to co-exist with the lowest-energy, fully DHI tetramer. Remarkably, the calculated 
UV-Vis spectrum of averaged mixtures of tetrameric molcules would indeed reproduce the 
monotonic absorption of eumelanin in this range,[261] and its characteristic, ultrafast thermal 
relaxation upon photoexcitation.[262] On the other hand, calculations also showed that stacked 
aggregates of these porphyrin-like rings would feature interplane distances consistent with 
those obtained from X-ray diffraction of eumelanin. Overall, these calculations would both 
support the chemical disorder hypothesis, and a stuctural framework made of oligomeric 
structures,[261] although covalently-linked oligomers, either stacked,[ 263 ] or in helical 
configurations, might also be feasible.[264] On the experimental side, investigations on soluble 
synthetic analogues of melanin by Pezzella et al. suggested that the ‘chemical disorder’ model 
would be feasible, with co-existing catecholic and quinoid moieties in dynamic equilibrium and 
quinones accounting for the dark coloration, notwithstanding light scattering effects.[265] On 
the other hand, neuromelanin has been described as composed of granules around 30-nm 
diameter consisting of pheomelanin at the core and eumelanin at the surface.[266]  
In recent years, the most widely researched synthetic analogue of melanin has likely been 
Messersmith’s polydopamine,[72] reviewed in Section 2, to which the reader is referred. Suffice 
it to say here that, in addition to a similar chemical base, polydopamine and eumelanin share 
many characteristic traits, such as a deep dark colour, similar FT-IR, ESR,[267] and XPS 
spectra,[268] and a similar structure of -  stacked aggregates,[269] and the coexistence of 
catecholic and quinoid units in the same macromolecular scaffold.[260,72] Indeed, synthetic 
melanin may be prepared by autooxidation of DOPA in mild alkaline aqueous media,[270] in 
conditions similar to those used for the preparation of polydopamine from structurally related 
dopamine.[72] 
Another important feature of melanins, which is mentioned in Section 6, is its siderophore-like 
ability to scavenge heavy metals in vivo, as observed, for example, in several melanized 
funghi.[271,272] In humans, iron-melanin binding in brain’s substantia nigra, likely resulting in 
intraneuronal production of free radicals, has been linked to the pathogenesis of Parkinson’s 
disease.[273, 
274] Since, in general, pigmented tissues present a significant amount of metal ions 
in vivo, the role of melanin as chelating agent and its metal-binding capacity have been subject 
to extensive research.[275] On the other hand, the in vitro chelating affinity of melanin for a 
variety of metal cations was already studied by Sealy and co-workers,[270] who attributed this 
versatility to the simultaneous presence of several functional groups in the molecule. Although 
the indolic nitrogen and the carboxylate group (in DHICA) participate in the binding ability of 
DHI to metal centers, catechols were recognized as essential for binding at neutral-basic 
pHs.[247] 
As recently pointed out by d’Ischia and co-workers,[253] melanin may be considered a 
multifunctional material in which catechol units play an essential role. While recognizing the 
significant potential of eumelanin as a functional material, the authors conceded that control 
over the aggregation state of melanins, and hence over its solubility,[265,276,273] should be 
essential for future developments in this field. Meanwhile, Meredith and co-workers have 
reported the preparation of free-standing melanin films by electrochemical oxidation of 
DOPA,[277,278] and device-quality thin films of synthetic melanin,[279] by dissolution of synthetic 
eumelanin in concentrated ammonia, spin casting on glass and silicon substrates and final 
evaporation of the solvent/reagent; cast films showed characteristic properties of eumelanin, 
such as similar UV-Vis absorption profiles and an electrical conductivity of 2.5·10-5 S·cm-1 at 
room temperature and 100% relative humidity. Furthermore, synthetic melanin films 
presented excellent thermal stability and resistance to photobleaching. The electrocatalytic 
and magnetic properties of ultrathin nanostructured iron-melanin films have also been 
studied, showing catalytic activity for the electroreduction of hydrogen peroxide in alkaline 
and neutral solutions.[280] Another significant step towards the integration of melanin-based 
biopolymers into devices, has been the synthesis of a hybrid melanin/silicon interface, which 
shows interesting electronic properties and enables insight into electrical transport 
mechanisms operating, which have been found to be linked to the melanin hydration state.[281]  
A composite of chitin and melanin has been recently used in order to successfully reproduce 
the nano-scale antireflection structure of the black scales in the Troides aeacus butterfly wing, 
which can be viewed as a natural solar collector. The antireflection behaviours of the black 
scales were measured and modeled, showing that the antireflection property is caused by the 
coupled effect of ridges and nano-hole arrays of the scales;[282] the periodically aligned inverse-
V type ridges transfer light beams to the nano-hole area where the light-trapping effct occurs. 
Both natural and synthetic melanins have been also described as thermooxidative stabilizers of 
polymers, increasing the decomposition temperature for poly(methylmethacrylate) by about 
50-90 ºC.[283] 
 
5.3. Catechol-based Nanoparticles. 
Polydopamine can be prepared as nanocapsules[284,285] and nanoparticles,[267] in the latter case 
resembling eumelanin particles that constitute Sepia ink. Particularly, polydopamine 
nanocapsules have been prepared using several different template strategies. In a recent 
study, the Zhou group reported the deposition of polydopamine on SiO2 nanoparticles and 
further dissolution of the silica core with HF. Shell thickness could be controlled by the number 
of repeated coating cycles, which was convenient since it allowed the preparation of 
sufficiently robust capsules that didn’t crack upon drying. On the other hand, capsules were 
permeable, and able to uptake rhodamine 6G (Rh6G) in aqueous solutions, especially at high 
pHs, while releasing the dye in ethanol.[284] In a follow-up study, the pH-controlled uptake and 
release of three dyes with acid-base activity (methyl orange –MO-, alizarin red and Rh6G) by 
polydopamine microcapsules, fabricated by coating of polystyrene microspheres followed by 
dissolution of the PS core by THF, was studied. MO and alizarin red were selectively uploaded 
at acid pH, whereas Rh6G was uptaken at basic pHs, in accordance with the surface charge of 
polydopamine and the net charge on each dye molecule, each pH dependent. Controlled 
release was observed in reversed pH conditions.[286] An alternative method reported by Caruso 
et al. described the preparation of dopamine nanocapsules by o/w emulsification, stabilized by 
partial condensation of dimethyldiethoxysilane (DMDES). The function of this polymer was to 
entrap insoluble payload and to serve as template for the polymerization of an outer 
dopamine layer. Later on, the DMDES core was solubilized in ethanol, leaving the cargo 
entrapped inside the polydopamine shell. This strategy made possible the fabrication of nano- 
and microcapsules with a high degree of monodispersivity. As proof-of-concept of this 
encapsulation strategy, functional components, such as magnetic Fe3O4 nanoparticles, 
fluorescent QDs (CdSe/CdS), and an anti-cancer drug (thiocoraline), were successfully 
encapsulated.[285] Jiang and co-workers reported the sequential incorporation of three 
different enzymes inside, within, an onto polydopamine microcapsules, respectively. The first 
enzyme (glucosidase) was encapsulated inside the microcapsule after dopamine was 
polymerized in the presence of this enzyme and onto polystyrene sulfonate (PSS)-modified 
CaCO3 3 m-microparticles, and the CaCO3 inner core was later dissolved with EDTA. A second 
coating of polydopamine was carried out in the presence of a second enzyme (ß-amylase), 
affording the entrapment of the enzyme within the polydopamine shell. Finally, treatment of 
the polydopamine capsules with -amylase led to the adsorption of this enzyme on the surface 
of the microcapsules.[287] In a follow-up study, microcapsules with hybrid inorganic/organic 
shells were obtained by coating PSS-modified CaCO3 with a first layer of TiO2 or SiO2 
precipitated from soluble precursors in the presence of protamine, and subsequent deposition 
of polydopamine. The inorganic, biomineralized inner crust was shown to stabilize the organic 
outer layer, particularly in the case of TiO2, thanks to the strength of catechol-Ti bonds. The 
porosity and thickness of the capsules could be controlled by careful choice of reagent 
concentrations and coating conditions.[288] 
Recently, Lee and co-workers reported a simple procedure for the generation of melanin-like 
nanoparticles by oxidative polymerization of dopamine in basic aqueous media and vigorous 
stirring. By careful control of the reaction conditions, <100 nm nanoparticles of polydopamine 
were obtained, which were more monodisperse than melanin nanoparticles obtained from 
Sepia ink (100-300 nm). Spectroscopic data of the synthetic nanoparticles were very similar to 
those of the natural Sepia eumelanin, including the observation of an ESR signal arising from a 
certain amount of free radicals in both –synthetic and natural- polymers. The surface of 
synthetic melanin NPs could be modified by adding a thiol-capped-PEG, which made the NPs 
dispersible in aqueous media. NPs were found to be non-toxic toward HeLa cells, and showed 
radical scavenging capacity, which increased with decreasing NP size. For the smallest NPs (<70 
nm), this capacity was shown to be comparable to that of ascorbic acid.[267] 
Inspired by biomimetic analogues of Mefps, Deming and co-workers prepared DOPA-
containing polypeptidic block copolymers that proved to self-assemble into nanometer-sized 
vesicles. In a similar way to Mefps, DOPA moieties cross-link the peptidic shell upon addition of 
an oxidizing agent (NaIO4), yielding very stable vesicles, which were resistant against organic 
solvents, high-osmotic pressure aqueous media and temperature, without rupture, and 
capable of retaining their payload -a fluorescent dye-, without cross-linking having any effect in 
the amount of encapsulated dye. As opposed to DOPA-containing vesicles, polypeptidic 
scaffolds without DOPA were disrupted by these environmental stress tests.[289] 
 
5.4. Assisted fabrication of materials. 
Dopamine and DOPA-bearing polymers have been shown to aid in the crystallization of 
inorganic materials, such as TiO2,
[290] vaterite-CaCO3
[291,292] and noble metals[293] in the form of 
nanoparticles. Messersmith et al. prepared coated gold and silver NPs by taking advantage of 
the reducing character of catecholic moieties. A tetraDOPA-PEG molecule was shown to react 
with AuIII and AgI from aqueous basic solutions to yield the corresponding native elements in 
<100 nm nanoparticles coated with oxidized, cross-linked forms of the parent molecule. These 
NPs presented plasmonic resonances in accordance with their respective sizes and stability in 
solution thanks to the protective coating afforded by the tetraDOPA-PEG layer (<10 nm).[293] 
Applications involving the dopamine-assisted precipitation of Ag nanoparticles by in situ 
reduction of Ag+,[77,199,141,146] and Au NP from AuCl4
-,[101,102,103] are discussed in chapter 2.1. 
Tremel and co-workers described an easy, robust procedure for the preparation of 
functionalized, monocrystalline rutile TiO2 nanorods in mild conditions. TiO2 was prepared by 
aqueous hydrolysis of TiCl4 in the presence of dopamine, followed by aging and hydrothermal 
treatment at 150 °C. Dopamine, which ended up surface-bound, was shown to control the 
morphology as well as the crystallinity and the phase selection of TiO2. Moreover, the 
availability of the amine terminal groups of anchored dopamine afforded further 
functionalization of the nanorods (e.g. with dye 4-chloro-7-nitrobenzofurazan).[290] 
In a series of recent studies on the preparation of biocompatible materials, Park et al. showed 
that calcium carbonate can be precipitated into the unstable vaterite phase in the presence of 
dopamine. Further incubation of dopamine-stabilized vaterite microparticles in simulated body 
fluid during 48 h afforded the conversion of vaterite into carbonated hydroxyapatite, which is 
biocompatible and very similar to natural bone. Blank experiments without dopamine showed 
the formation of calcite phases in the same experimental conditions. Due to its stability, calcite 
didn’t extensively dissolve in the same incubation conditions, and thus didn’t precipitate as 
hydroxyapatite. When intermediate amounts of dopamine were used, mixed vaterite/calcite 
phases were obtained.[291,292] In a follow-up study, the authors reported that dopamine-coated 
Ti substrates could be coated with hydroxyapatite crystals when incubated in simulated body 
fluid solutions. Polydopamine was thus shown to be essential as nucleating material for 
hydroxyapatite and effective as a universal strategy for biomineralization, in which a bone-like 
material (hydroxyapatite) may be successfully integrated with materials of a varied nature and 
different compatibility, such as metals, ceramics, organic polymers, and porous materials and 
fibers, such as cellulose.[294] Similar results were obtained with dopamine-coated carbon 
nanotubes, which were found to be less cytotoxic for osteoblasts than bare CNTs, opening the 
possibility of using CNTs for applications in bone-related therapies.[295] In a very recent study, 
polydopamine is used to coat self-assembled nanowires of diphenylalanine intended as 
substrates for the growth of hydroxyapatite. The authors suggested that the layered structure 
of polydopamine directed the growth of hydroxyapatite crystals and of preosteoblasts on top, 
in a process reminiscent of the biomineralization of collagen.[269] Similarly, Wu et al. reported 
that polydopamine assisted apatite mineralization when used to improve the biocompatibility 
of mesoporous silica for bone tissue regeneration, affording better attachment of bone 
marrow stromal cells and sustained release of dexomethasone.[296] 
 
5.5. Nanovessels. 
Catechols have also been reported for the controlled design of functional, non-polymeric 
scaffolds. Raymond and co-workers showed that carefully designed ligands, such as N,N′-
bis(2,3-dihydroxybenzoyl)-1,5-diaminonaphthalene, self-assemble via catecholate chelation in 
aqueous media around certain trivalent (FeIII, GaIII, AlIII, InIII) and tetravalent cations (TiIV, GeIV) 
capable of octahedral coordination, to form tetrahedral organometallic clusters with a M4L6 
stoichiometry.[ 297 , 298 ] In these complexes, chiral metal ions occupy the vertices of the 
tetrahedron, while ligands span the structure’s edges, forming stable, non-interconvertible 
enantiomeric structures of 300-500 Å able to act as both as protective cages and nanovessels. 
With an overall electric charge of -12 for the trivalent species, the assembled cages are ideally 
suited for the encapsulation/protection of cationic species of appropriate size, and have been 
found to catalyze a variety of chemical reactions and physico-chemical effects on guest 
molecules, among which, aza-Cope rearrangements,[299,300,301] the activation of C-H bonds in 
aldehydes,[302,303] the isomerization of allylic alcohols,[304] the stabilization in basic aqueous 
media of reactive cationic species,[305,306,307] and the enhancement of the basicity of amines.[308] 
Reactions that are usually acid-catalyzed, such as the deprotection of acetals[309] and the 
hydrolysis of orthoformates,[310 311] have been realized in basic media by addition of catalytic 
amounts of the GaIII cluster.[310] Once assembled, the catechol complexes were shown to be 
robust enough, regardless of the trivalent metal used, so that host exchange was facilitated 
through minor openings by structural, elastic deformation of the cage, rather than its partial 
dissociation via edge rupture and re-assemblage.[173] Remarkably, these M4L6 complexes, 
dubbed “nanozymes”,[309] have been shown to rely exclusively on electrostatic and 
hydrophobic interactions for thermodynamic stabilization of protonated guest species, and 
exhibit enzyme-like Michaelis-Menten kinetics for catalytic hydrolysis reactions taking place 
inside the host.[310]  
  
6. Siderophore-like materials. 
 
In order to regulate key metabolic routes, most living organisms need to take in iron from the 
environment, and be able to efficiently and reversibly regulate its metabolic concentration by 
means of specific transport and storage mechanisms. Because of the very low solubility of FeIII 
in a broad range of pH, the bioavailability of FeIII is very poor despite its otherwise natural 
abundance, and specific strategies have evolved to acquire this essential need. In this regard, 
bacteria secrete powerful chelating agents known as siderophores in order to scavenge FeIII 
from their surroundings.[312,313,314] In conditions of iron deprivation, the role of siderophores is 
crucial for the survival and proliferation of microorganisms, especially for infectious bacteria, 
since hosts become the only immediate source of FeIII. Not surprisingly, the virulence of certain 
infectious diseases is related to the efficacy and versatility of the secreted siderophores, and 
enhanced by a higher availability of physiological iron.[315] On the other hand, in order to fulfill 
their own metabolic needs and because of the inherent toxicity of free iron, animals use 
specific proteins, such as hemoglobin and ferritin, to carry and store iron, so that its 
concentration as a free species is kept extremely low at all times.[316] In turn, animal hosts must 
mobilize their immune system to inactivate siderophores secreted by infectious 
microorganisms.[317,318] 
Several different chemical functionalities, such as hydroxamates and carboxylic acids, are 
known to serve the purpose of iron chelating moieties. Particularly, catechol (o-dihydroxyaryl) 
units are often found in natural siderophores because of the excellent affinity for FeIII. Simple 
catecholic molecules, such as 2,3-dihydroxybenzoylglycin –the first natural catecholic 
siderophore to be isolated -,[319] 2,3-dihydroxybenzoic acid and 3,4-dihydroxybenzoic acid have 
been identified as natural siderophores, in the latter case secreted by microorganisms with 
unusually high iron requirements.[320] Most catecholic siderophores, though, feature rather 
complex multipodal structures, having two or three catechol-based pendant groups attached 
to a common scaffold for a more efficient coordination of the metal center. Regardless of 
chemical functionality, the strongest natural siderophore known to date is enterobactin,[321,316] 
a tripodal catecholic compound secreted by many Gram negative bacteria, among which E. 
coli. The chemical structure of enterobactin comprises three L-serine residues linked head-to-
tail into a trilactone platform, to which are attached, cage-like, three pendant N-2,3-
dihydroxybenzoyl groups. The six catecholic oxygen atoms define a hexadentate binding site, 
and are optimally directed for a strong octahedral coordination of the metal center. Similar, 
well-known tris-catechol-based siderophores are bacillibactin,[ 322 ] secreted by Bacillus 
antracis,[ 323 ] and vibriobactin, isolated from Vibrio cholerae.[ 324 ] Once bound to FeIII, 
siderophores are recognized by specific receptors located on the outer membrane, which 
allow them to re-enter the bacterial cell. In order to maximize iron uptake capacities, single 
bacteria species are able to fabricate different types of siderophores,-such as catechol-based 
and hydroxamate-based-, for which they have several non-specific and specific 
receptors.[313,314] In a complementary fashion, there exist a few mixed-ligand natural 




6.1.  Artificial siderophores. 
Artificial siderophores are synthetic chelating agents of FeIII intended as therapeutic agents 
specifically used for the treatment of both acute and chronic iron poisoning. The latter arises, 
for example, as a side effect in ß-thalassemia patients subject to chronic blood transfusions, 
leading to iron overload, for which the human body has no expedient remedy. Desferal® 
(desferrioxamine B mesylate, a hydroxamate-based drug) was approved more than 30 years 
ago and is still the most widely used siderophore drug. Despite being a strong in vitro ligand for 
iron, Desferal® shows limited in vivo bioavailability, and is not effective when administered 
orally, needing a continuous parenteral infusion for optimal efficacy, often conducive to low 
patient compliance.[325] 
In the quest for new siderophore drugs with better pharmacological profiles, siderophore 
scaffolds based on catechol and catechol isosteres have been tested.[326] Among many 
potential candidates, several small catechol-like derivatives, including 2,3-dihydroxybenzoic 
acid,[327] were already tested in vivo in the mid 1970s, of which 2,3-dihydroxynaphthalene-6-
sulfonic acid showed potential therapeutic activity.[328] Among recently approved drugs, 
Ferriprox® (Deferiprone, or 3-hydroxy-1,2-dimethylpyridin-4-one,),[329] a small heterocycle and 
catecholate isostere, may be taken orally and has shown promising results compared to 
Desferal®.[330]  
Catechol derivatives as synthetic siderophores have been researched extensively.[331] Early 
studies by Raymond and co-workers focused on homopodal enterobactin mimics like 1,5,9-
N,N’,N”-tris(2,3-dihydroxybenzoyl)cyclotriazatridecane,[ 332 ] and 1,3,5-Tris-(2,3-dihydroxy-
benzoylaminomethyl)benzene,[333] as well as heteropodal mimics such as 3,4-LICAMS ,[325] that 
preserved a tris-catecholate cage, but in these cases linked to backbone caps less prone to 
hydrolysis. In 3,4-LICAMS, sulfonic acid groups were added to the catechol rings for enhanced 
solubility and stability toward oxidation. Unlike Desferal®, but in a similar fashion to 
enterobactin, 3,4-LICAMS was able to kinetically mobilize iron from transferrin in vitro, and 
showed that a rational strategy may be used for the design of ligands with optimal metal 
chelating properties.[334,331] Research has also focused on the synthesis of mixed-ligand 
siderophores, in which at least one chelating moiety is catecholic, for example mono-catechol 
bis-hydroxamate-[335] and bis-catechol mono-hydroxamate ligands.[335,336] Other catechol-based 
ligands, such as 2,3-dihydroxyterephtalamide, have been used to prepare pure- and mixed-
ligand siderophores with a very high affinity for FeIII, while at the same time being stable to 
oxidation and presenting low acidity.[337] The use of systematic substitution of two different 
ligands in these siderophores proved effective in the fine-tuning of these critical physic-
chemical properties.  
Catechol isosteres such as substituted 3-hydroxypyridin-2-ones (3,2-HOPO),[337,335,326] and 
catechol-hydroxamate isosteres like 1-hydroxypyridin-2-ones (1,2-HOPO),[ 338 ] have been 
thoroughly studied with regard to the improvement of their metal chelating properties. In 
particular, it has been shown that a proper cap size facilitates an optimal accommodation of 
the ligands around the metal center.[339] Moreover, the existence of a cap forming a joint 
hexadentate ligand structure dramatically increases the effectiveness of the ligand itself, 
compared with the analogous isolated (bidentate) ligand. With regard to their pharmacological 
properties, they showed low toxicity in vivo and higher efficacy than desferrioxamine. An 
additional advantage of 3,2-HOPO moieties over true catecholic residues lies in their higher 
acidity, which readily allows deprotonation of the hydroxy group for FeIII coordination at 
physiological pH.[340] 
Because of the sensitivity of catechol toward oxidation in the presence of air, especially at 
basic pH, and oxidative species, such as FeIII itself, the stability of catechol-based siderophores 
has to be taken into account for practical applications, and may be tuned by the electronic 
properties of the ring pendant groups.[341] Of importance is also the hydrophilic/lipophilic 
balance in the siderophore, which can be adjusted by incorporating lipophilic side chains in the 
molecular structure, reminiscent of the amphiphilic siderophores secreted by certain marine 
bacteria.[342] In buffered aqueous environments, synthetic amphiphilic siderophores have been 
shown to self-assemble into micelles and vesicles,[343] or spherical particles (100-300 nm),[342] 
depending on the presence or absence of a sulfonic acid substituent on the catechol ring. 
Kikkeri et al. have recently reported on a novel family of siderophores that combine 
siderophore-like catechol moieties with carbohydrate units arranged in dendritic structures. 
The authors showed that E. coli was able to use these chelating agents for iron uptake and 
growth promotion via specific sugar receptors in the cell membrane.344 
 
In addition to their special affinity for iron, natural siderophores are effective chelating agents 
for other metals. The ligand properties of enterobactin toward trivalent species (AlIII, GaIII, ScIII, 
InIII),[345] and the crystal structure of a enterobactin-VIV complex have been reported.[346] Other 
natural hydroxamate-catechol siderophores such as pyoverdin and azoverdin have been 
shown to form stable coordination complexes with GaIII, AlIII,[347,348] and UO2
2+.[349] These 
complexes are so stable that the presence of AlIII and GaIII interfere with FeIII absorption in 
biological media.[347] Not surprisingly, synthetic catechol siderophore mimics also form stable 
complexes with trivalent species.[345] More intriguing is the biological role siderophores may 
play for nitrogen-fixating bacteria (diazotrophs), which must take in both FeIII and MoVI for 
their metabolic process, particularly nitrogen fixation. Siderophore-MoVI complexes are 
tetradentate, with two catechol moieties coordinating the vertices of a distorted octahedron, 
while the other two are occupied by oxygen atoms. Although it is still unknown if siderophores 
partake in MoVI scavenging, or whether specific Mo-siderophore receptors exist in the outer 
cell membrane, catecholic bipodal siderophores such as azotochelin,[350] and monopodal 
aminochelin,[351] also bind MoVI in vitro, which has been shown to delay the in vivo iron uptake 
by these siderophores.[352] 
In this broader role as powerful generic transition metal ligands, synthetic siderophores have 
been tested for in vivo radioisotope decontamination. For tetravalent ions such as ThIV and 
PuIV, tetrakis-catechol-based ligands  were specifically designed for optimal octadentate 
coordination and solubility in physiologic media.[353,354,355] These ligands showed better in vivo 
Pu scavenging capacity than both CaNa3DPTA and desferrioxamine B, particularly at low 
actinide concentrations; moreover, the ligand was able to remove.[238] Pu already deposited in 
the skeleton. A more recent, detailed review covering the use of siderophores for actinide 
sequestration,[ 356 ] concluded that, in general, tetradentate and octadentate catechol-, 
dihydroxyterephthaloyl- as well as isostere hydroxypyridone-based ligands are more efficient 
than DPTA-based ligands -the only ones approved for medical use-, and more selective toward 
actinides, especially in the case of Np, for which DPTA is not effective.[357] Because of the high 
selectivity of each different ligand, a cocktail of ligands was suggested as a suitable 
prescription for generic radioisotope decontamination. Miao and Quinn reported an 
interesting reverse strategy involving catechol-radionuclide coordination in preliminary in vivo 
tests for peptide-targeted radionuclide therapy for melanoma, where radiolabeled peptides 
ended up selectively bound to 5,6-dihydroxyindole-based eumelanin and associated receptors, 
which are over-expressed by melanoma tumor cells.[358] 
 
Using boron instead of FeIII, catechol coordination has been further explored by Messersmith 
and co-workers for cancer therapy. A modular molecule comprising PEG covalently linked to 
dopamine and fluorescence-tagged biotin was synthesized, where the catechol moiety was 
able to bind to a boronic-acid-based anti-cancer drug at basic pH, and reversibly release said 
drug in acidic conditions. The biotin moiety allowed the assemblage to sneak through cell the 
membrane and thus be uptaken by cells, whereas the PEG moiety allows the complexed drug 
to survive longer in the body prior to liver degradation. By taking advantage of the fact that 
both cancer cells and extracellular interstices in tumors present lower-than-normal (acidic) pH, 
this strategy was proven to increase the selectivity of the uptake and release of this anti-
cancer drug by cancer cells, as compared to normal cells.[359] 
 
6.2. “Trojan horse” therapeutic agents. 
Sideromycins are naturally occurring FeIII-siderophores secreted by several fungi and bacteria 
species that are covalently linked to an antibiotic moiety.[360] Using a Trojan horse or active 
transport strategy, sideromycins are channeled through the specific iron-uptake paths of 
competitor micro-organisms, which would otherwise be able to block the free antibiotic. 
Although most sideromycins are hydroxamate-based, a few natural catechol-based are known. 
For example, among microcins, gene-encoded antibacterial peptides with potent antibacterial 
activity against closely related species,[361] - type E492 produced by Klebsiella pneumoniae was 
shown to consist of an enterobactin-like tris-N-(2,3-dihydroxybenzoyl)-L-serine end-cap, linked 
to a natural antibiotic oligopeptide via a glucose unit,[362,363,364] whereas other microcins are 
suspected of requiring catecholate siderophore receptors for antibacterial activity.[365] 
Synthetic siderophore-drug conjugates using a Trojan horse strategy have been widely 
researched because of their promising therapeutic value.[366,367,368,315369,370] Since FeIII uptake is 
essential to infectious bacteria, such synthetic conjugates may be used to target bacteria, like 
Pseudomonas aeruginosa, that are notorious for their natural and growing resistance to most 
known antibiotics. An early study on a catechol-cephalosporin drug already showed enhanced 
antipseudomonal activity of this conjugate with regard to the unmodified ß-lactam antibiotic. 
371 This effectiveness was lost on mutant strains in which the membrane iron-transport system 
had been suppressed, pointing unequivocally to a siderophore-dependent transport of the 
antibiotic inside the bacterial cell.[366] Since cephalosporin and penicillin antibiotics are 
generally cheap and commercially available, their covalent conjugation to siderophores to 
obtain potent drugs is advantageous.[372] 
In order to minimize resistance by receptor-deficient mutants, mixed-ligand siderophore-drug 
conjugates intended to target multiple receptors have been tested, for example 
carbacephalosporins bearing bis-catechol-mono-hydroxamate hybrid siderophores.[373,374,375,376] 
It was suggested that selected mutant strains showing resistance would be, at the same time, 
severely iron-deprived for lack of proper iron-uptake routes, which would make them 
intrinsically less virulent. Moreover, despite the inability to deliver the antibiotic moiety, the 
presence of the siderophore-antibiotic conjugate in the surroundings of the infection would 
further contribute to the scarcity of available iron, still essential for bacterial growth.[373] 
In addition to catechol-cephalosporin conjugates,[371,373,377] which still represent one of the 
most actively researched siderophore-drug families,[368] isostere 3-hydroxypyridin-4-one-based 
conjugates have been found to present excellent antibiotic efficacy against Staphylococcus 
aureus,[378] and promising in vivo results for multi-drug resistant Acinetobacter baumannii 
strains.[ 379 ] Other than ß-lactams, different kinds of antibiotics have been successfully 
conjugated to catechol moieties to render active antibacterial conjugates, such as 
quinolones.[380] Further investigation has focused on improving the pharmacological properties 
of catechol-based drugs by esterification of the hydroxyl groups.[381,382,383,384] It is claimed that 
the esters are cleaved under physiological conditions, which would explain the high activity 
shown by these “pro-drugs”. 
Apart from antibiotics, other conjugate partners for siderophores have been studied, such as 
porphyrins for photodynamic therapy.[385] Finally, it should be mentioned that substituted 
catechols and catechol isosteres have been found to inhibit specific enzymes, such as 
lipooxygenases,[386] and deoxyhypusylhydroxylases.[387,388] In both cases, the chelation of the 
iron atom at the active site of the enzyme was assumed to be a key step in the inhibition 
mechanism. 
 
6.3. MRI contrast agents. 
Gadolinium complexes, among which novel ligands bearing catecholic and catechol-isostere 
units, have been thoroughly studied and recently reviewed,[389,390] because of their potential in 
the on-going quest for highly effective contrast agents for magnetic resonance imaging 
(MRI).[391] Homopodal ligands bearing three 3-hydroxypyridin-2-one (3,2-HOPO) units,[392] and 
heteropodal variants of the same, where other catecholic chelators such as 2,3-
dihydroxyterephthalamide (TAM) substitute in for one of the 3,2-HOPO units,[393] showed 
relaxivity values that doubled those of clinically employed polyaminocarboxylate complexes 
(Ca. 5 mM-1·s-1). The affinity of the ligand for GdIII was found suitable to avoid transmetalation 
by physiological CaII leading to significant liberation of the in vivo-toxic, free lanthanide ion. 
These high relaxivities were explained by the fast exchange of water molecules between the 8- 
and 9-coordinated species in equilibrium, in which water molecules enter and leave the two or 
three remaining sites that, respectively, complete the coordination sphere of the GdIII atom. A 
screening of heteropodal variants of the mixed 3,2-HOPO/TAM ligands proved that it is 
possible to tune the overall basicity of the ligand in order to maximize the stability of the GdIII 
complex at physiological pH.[394,395] An additional advantage offered by the inclusion of a TAM 
group was the possibility to functionalize the 4 position with PEG chains of varying length, 
which conferred varying degrees of hydrophillicity to the complex that correlated with a 
selective final in vivo distribution of the molecule, either to the liver or the blood pool.[396] 
More recent attempts to increase the molecular relaxivity value of the GdIII complex focused 
on the covalent binding of the optimized ligand to bulky supramolecular structures of high 
molecular weight and low tumbling rates. In one study, estearamide- and branched polylysine-
based dendrimers were functionalized with up to 6 tripodal HOPO-based ligands. The best 
relaxivity values where obtained with the estearamide-based dendrimer (38 mM-1·s-1). These 
macromolecules offered an attractive alternative to other tested probes in view of their low in 
vitro cytotoxicity and favorable degradation profiles, as shown by the low toxicity values 
obtained after 72h in in vitro biological conditions and up to milimolar concentrations of the 
dendrimer-based contrast agent.[ 397 ] In another, biomimetic approach, capsids of the 
bacteriophage virus MS2 were emptied of RNA strands and both the exterior and interior-
facing lysine residues and exterior-facing tyrosine residues were functionalized with groups 
bearing terminal aldehyde groups, which in turn were reacted with a properly activated 
tripodal HOPO-based complex. The final functionalized capsids, bearing each up to 90 HOPO 
anchors for GdIII complexation, showed very high relaxivity values (30-42 mM-1·s-1 per GdIII unit) 
while at the same time retaining the necessary fast water-exchange capabilities. In the case of 
the interior-functionalized capsid (42 mM-1·s-1 per GdIII unit), the latter took place thanks to 
the porous shell structure of the capsid. This was found particularly convenient, since the 
capsid may carry its payload (HOPO- GdIII) concealed in the interior, while at the same time 
showing a clean outer surface available for biorecognition.[398] 
Using a different supramolecular approach, Parac-Vogt and co-workers prepared a ditopic 
chelating ligand bearing both catechol and carboxylic acids groups that was shown to 
specifically bind trivalent lanthanide ions through the carboxylic acid moieties, and TiIV via 
catechol groups. The resulting Gd-“metallostar” showed magnetic relaxivities almost an order 
of magnitude higher than a currently commercial MRI contrast agent.399 
 
6.4. Luminescent probes. 
Lanthanide complexes with ligands carrying catechol-isostere HOPO-based chelating units 
have been reported for their use as efficient luminescent probes in highly-sensitive 
fluorescence immunoassays.[ 400 ] As opposed to traditional dissociation-enhanced assays 
(DELFIA), in which the photosensitizing species is added at the end of the assay, the purpose of 
these studies lies in finding efficient photosensitizers capable, at the same time, to chelate the 
metal ion in a strong and stable fashion in very dilute aqueous media and during long assay 
times. This way, an inherently highly fluorescent lanthanide-photosensitizer complex would be 
added at the beginning of the assay, and the fluorescent signal would be followed throughout, 
ideally without being impaired by the solvent. The first examples of HOPO-sensitized 
lanthanides were tetrakis-1,2-HOPO complexes of EuIII and TbIII, for which either poor, or 
efficient photosensitizing effects in solid-state samples were reported, respectively.[ 401 ] 
Solution luminescence measurements were carried out on a dimeric EuIII complex of a bipodal 
1,2-HOPO-based ligand, which was found to exhibit excellent stability in aqueous media and 
almost pure red fluorescence with a high quantum yield and long lifetime (>700 s). This was 
attributed, in part, to the fact that the metal center is well shielded from water molecules, 
thus dramatically decreasing the rate of solvent-induced fluorescent quenching.[402] In contrast 
with 1,2-HOPO,[402,403] similar 3,2-HOPO-based ligands did not sensitize EuIII, but were able to 
do so for HoIII and PrIII, in this case in the NIR range, thus accounting for the few examples 
known of NIR emission by these lanthanide ions.[404] Similar complexes showing exceptionally 
high quantum yield and very long lifetime luminescence in the NIR region and excellent 
stability in solution were prepared with bi- and tetrapodal 1-methyl-3,2-HOPO-based ligands 
with YbIII and NdIII,[405] making them excellent candidates for bioassays, in which, because of 
the large separation between excitation and emission wavelengths, NIR imaging/detection 
should provide better resolution of the fluorescent signal. 
 6.5. Heavy metal scavenging. 
Heavy metal accumulation in the environment affects crop health and safety,[406] as well as the 
health of soil micro-organisms.[407] Although the natural propensity of plants to take up metals 
is detrimental to human health when intended as food sources, they offer, on the other hand, 
a tool for phytoremediation of contaminated soils. In order to enhance heavy metal 
mobilization and facilitate the uptake by the plant, chelating agents may be added to the 
soil.[408] Among them, naturally occurring humic acids, made up complex, alkaline-soluble 
macromolecules bearing polyphenolic, catechol and quinoid moieties, have been studied as 
soil additives capable of heavy metal chelation and a subsequent increase in mobility and 
bioavailability of these pollutants to suitable, metal-hyperaccumulating plant species.[409] 
Alternatively, several rhizobacteria known to be tolerant to heavy metals in the soil,[410] can be 
inoculated, improving the uptake by so-called bioaugmentation.[411] Particularly, the addition 
of free and encapsulated cultures of siderophore-secreting bacteria, like pyoverdin-producing 
Pseudomonas aeruginosa, in maize crop soils has been shown to increase the concentration of 
PbII and CrIII by 4 and 5-fold in crop shoots, as well as a positive heavy metal transport from the 
roots to the shoots. Tests with mutant siderophore-deficient strains would confirm the 
positive role of siderophores in the overall process.[412] 
Certain fungi are known to secrete and accumulate insoluble, 5,6-dihydroxyindole-based 
melanins on the outer cell membrane. Melanized fungi show increased virulence and 
resistance to microbial attack as well as enhanced survival under environmental stress, 
particularly in heavy-metal contaminated soils, where pigmented strains have a survival 
advantage.[271,413,272,414] For instance, Armillaria rhizomorphs has been shown to concentrate 
heavy metals 50-100-fold with regard to the soil content,[415] whereas lichens have been found 
to inhabit uranium-polluted soils, where they use cell-wall melanin as a sequestrating 
agent.[416] In this regard, the combined use of melanized fungi and certain clays has shown 
potential for the removal of radionuclides like 90Sr and 137Cs.[417]  
Synthetic catechol-based stationary supports have been explored for the scavenging of heavy 
metals from aqueous samples. The sequestering capacity of these substrates was first tested 
on Tiron®-functionalized cellulose,[418] and polystyrene,[419] as well as 3,4-dihydroxybenzyl-
substituted poly(styrene-divinylbenzene, PS-DVB),[420] which showed affinity toward FeIII and 
HgII, respectively. As far as ion exchange resins are concerned, true selectivity for FeIII in 
aqueous environments with regard to other trivalent ions –such as AlIII and CrIII- and divalent 
species, was achieved by Fish and co-workers by applying a biomimetic approach, by which 
bipodal and tripodal, siderophore-like catechol-based pendant groups were used to 
functionalize a PS-DVB resin.[421,422,423] Changes in the scaffold to which the catechol groups 
were attached shifted the selectivity to divalent cations –NiII, ZnII, MnII, CuII- favoring square-
planar coordination.[ 424 ] A similar strategy was applied to non-aqueous media for the 
decontamination of oil shales and related pyrolysis products,[425,426,427] where a suitably 
modified PS-DVB resin showed chelating capacity toward arsenic and organoarsonic acids. The 
resin could be regenerated with quantitative recovery of As in the first 10 min. 
In the past years, catechol-derivatized porous substrates have been studied regarding their use 
in analytical methodologies involving the pre-concentration of heavy metals present in trace 
amounts in waste waters and commercial drugs. In this case, emphasis was put not on the 
selectivity of catechol residues toward a specific species, but on the general chelating 
properties of the catechol moiety,[428] and hence on its potential overall sequestering capacity 
of a wide variety of common metal pollutants. The polymeric support was thus used as an 
accumulator for the analytes, which were later quantitatively released in a much highly 
concentrated flow, coupled downstream to an analytical technique of appropriate sensitivity. 
So far, Amberlite XAD-2,[429,430,431] XAD-4,[432,429] XAD-16,[433,434,435] XAD-1180,[436] polyurethane 
foam,[437] polyacetylene,[438] silica,[439] and cellulose,[440] have been covalently functionalized 
with catechol moieties, and successfully used to quantify trace amounts of CuII, NiII , PbII, CdII, 
ZnII, CoII,[ 441 , 429-408,437,438] MnII,[432,433,430,435] UO2
2+,[432,433, 442 , 443 ] and ThIV.[442] In most cases, 
supports were easily regenerated and re-used multiple times. In a recent study, 3,4-
dihydroxybenxene-functionalized and pre-cross-linked chitosan was tested against 60 
prospective trace elements,[443] and later used for the continuous analysis of AgI, BiIII, CuII, GaIII, 
InIII, MoVI, V, NiII,[444] and UIV, proving particularly useful for the quantitative determination of 
the latter.[443]  
An alternative to the modification of commercially available microporous substrates was the 
fabrication of copolymers of 3,4-dimethoxystyrene (DMS) with divinylbenzene (DVB), with  
subsequent deprotection of the hydroxyl groups to yield a cross-linked vinylcatechol-DVB 
copolymer. In this case, the monomer ratio was found to be a compromising key factor, 
affecting both the degree of porosity and the chelating capacity of the resin.[445] A similar 
approach was used in the synthesis of a terpolymeric resin of vinylbenzene, divinylbenzene 
and N-substituted maleimide with a 3,4´-dihydroxyphenyl pendant group. In this case, the 
dihydroxyphenyl moiety was reacted with Ti(iPrO)4 to yield novel porous catalytic resins in 
which Ti coordinated with the hydroxy groups. These resins were found to exhibit very good 
catalytic activity toward model transesterification and epoxidation reactions.[446] 
  
7. Materials for chemo-/biosensing. 
 
Several quinones have been identified as co-factors of so-called quinoproteins, which include 
certain dehydrogenase and oxidase enzymes. In general, quinoid co-factors are involved in 
enzymatic oxidation processes in which o-quinone moieties oxidize specific substrates –usually 
alcohols and amines-, after which the corresponding reduced species is regenerated by an 
assisting electron acceptor.[447] Among o-quinoid co-factors, free pyrroloquinoline quinone 
(PQQ),[448] and enzyme-bound lysine tyrosylquinone (LTQ),[449] likely the most extensively 
researched to date, are known to oxidize alcohols and primary amines, respectively, to the 
corresponding aldehydes.[448,450] Particularly in the case of PQQ, the reduced species is 
assumed to be the catecholic dihydroxy compound,[451] which exemplifies the reversible redox 
role of the o-quinone/catechol pair in living organisms. In this regard, it has been suggested 
that PQQ may even qualify as a vitamin, because of its crucial role as a redox co-factor in the 
oxidative degradation of lysine observed in mice,[452] although this consideration still remains 
controversial.[453,454] From a biomimetic point of view, quinoid co-factors can thus be seen as 
paradigms of o-quinoid species thay may be reversibly converted into catecholic species by 
means of applied external stimuli, be it an electric potential (biosensors, biofuel cells, 
electrochromic materials and related devices), thermal energy (valence tautomerism) or 
electromagnetic radiation (dye-sensitized solar cells). 
 
7.1. NADH biosensing electrodes. 
The NADH/NAD redox pair is an essential coenzyme found in hundreds of dehydrogenase 
enzymes, which has led in the past years to a considerable interest in the design of different 
kinds of enzyme-based amperometric sensors. In solution, NADH is electrochemically oxidized 
at high overpotentials in an irreversible two step process involving an unstable radical 
intermediate species.[455] Because of this, electrodes based on the direct electrooxidation of 
NADH are subject to fast fouling, limiting in principle the development useful NAD/NADH-
based electrochemical devices. Efforts to overcome this hurdle started with an early study by 
Blaedel and Jenkins, who showed that pre-conditioned glassy carbon electrodes (GCE) 
afforded a significant decrease in the oxidation overpotential of NADH. The prior treatment of 
the electrode surface consisted of a series of repeated redox cycles, which afforded a 
chemically modified surface with different carbon oxide groups, such as carboxy, carbonyl, and 
quinoid structures. The authors hypothesized that these groups might be responsible for the 
observed decrease in the oxidation barrier of NADH.[456]  
Drawing on these results, Kuwana and co-workers suggested that a controlled chemical 
modification of electrodes might afford a satisfactory strategy for the selective oxidation of 
NADH.[457] According to this approach, an appropriate mediator species is physically or 
chemically bound to the electrode. When oxidized electrochemically, the mediator chemically 
oxidizes the final species of interest (NADH). Although many mediator species can be used for 
the oxidation of NADH, o-quinones have been shown to be especially apt for this purpose, 
because in addition to appropriate thermodynamic driving forces, they generally afford high 
reaction turnovers – particularly critical in the case of electrode-deposited monolayers of the 
mediator-.[458,459] Indeed, the kinetics of o-quinoid oxidation of NADH in aqueous media were 
explained after a series of detailed investigations by Miller et al., which revealed that quinones 
in general -and particularly o-quinones-, oxidize NADH by direct hydride transfer. This 
mechanism presents a lower energy barrier, compared with one-electron transfer processes, 
such as those afforded by the ferrrocenium ion, and is thus kinetically favored.[458] 
Different mechanisms to attach redox mediators to electrode surfaces have been tried so far, 
among which direct adsorption[460,461] or covalent binding[462,463,464] of monolayers of the redox 
mediator, in situ electropolymerization,[465,466] immobilization in a pre-cast lipidic film,[467,468] 
direct mix in a carbon paste,[469] and deposition of a polymer bearing redox moieties.[470] 
Examples of catecholic compounds explored as suitable redox shuttles include 
pyrocatechol,[471,472,473,474] 3,4-dihydroxybenzaldehyde,[475] 3,4-dihydroxybenzylamine,[476,477] 
dopamine,[463,477,467,464, 478 ] norepinephrine,[477,468] L-DOPA,[ 479 ] serotonin,[ 480 ] several 
arylalkylcatechols,[460,461] chlorogenic acid,[481] caffeic acid,[482] nordihydroguaiaretic acid,[483] 
pyrocatechol violet,[484] lignosulfonic acid,[485] and catecholic flavonoids, such as rutin[486] and 
quercetin.[464,487] A recent study by Bartlett and co-workers on the reversible catalytic oxidation 
of NADH systematically screened 13 different dihydroxybenzene derivatives covalently linked 
to GCEs by means of two different spacers, showing how the substitution pattern of the aryl 
ring affects both the redox potential and the surface coverage of the electrode.[488] As far as 
the final analyte is concerned, NADH has been studied preferentially, although other redox 
active species have been successfully detected with catechol-based electrochemical sensors, 
such as ascorbic acid,[486,468] phenylalanine,[469] dopamine[464,477] and captopril.489 ] Finally, 
although much work has been done on the modification of glassy carbon, graphite and metal 
electrodes with catecholic species, more recent work has explored the use of carbon 
nanotubes for the encapsulation of such materials for the detection of dopamine,[487] redox-
sensitive drugs,[489] the electrocatalyzed oxidation of hydrazine,[474] and the catalyzed oxidation 
of NADH.[490,480] A recent report by Gorski et al. showed that carbon nanotubes may be 
themselves activated for catalytic NADH oxidation by simply boiling them in water. Not only 
was this treatment mild and non-destructive, but the catalytic effect was much higher than 
that achieved by surface treatment of other carbon allotropes such as glassy carbon, graphite 
powder, and edge-plane pyrolytic graphite. As in the original work by Blaedel and Jenkins on 
GC, o-quinoid structures generated in the course of surface treatment were invoked as 
responsible for the catalytic effect.[491] 
Electropolymerization was chosen by Miller and co-workers to deposit PMMA polymer with 
pendant dopamine moieties on a GCE. The quinoid-rich film showed electrocatalytic activity 
toward the oxidation of NADH, which was highest at a monolayer degree of coverage, for 
which most dopamine units could be effectively oxidized to the corresponding dopaquinone 
species. In multilayer coatings, only the innermost layer -in direct contact with the electrode- 
provided significant amounts of electroactive dopaquinone necessary for the oxidation of 
NADH, while the outer polymer layers remained electrochemically inactive and acted as a 
barrier for the diffusion of NADH. The addition of electroactive species capable of mediating 
one-electron transfer processes, such as soluble ferrocene derivatives, were shown to enhance 
the catalytic activity of multilayer coatings, likely by mediating electron transfers between the 
inner and the outermost layers.[470,492,493] 
Jaegfeldt and co-workers adsorbed two different arylvinylcatechols on graphite electrodes 
taking advantage of the affinity between polycyclic aromatic moieties and the graphite 
surface. The electrode coated with 4-[2-(2-Naphthyl)vinyl]catechol showed electrocatalytical 
activity towards NAD/NADH.[460] When a more extended polycyclic aromatic system such as 
vinylpyrene was used as anchoring moiety, a detailed study of the catalysis kinetics toward 
NADH showed a progressive inactivation of the electrode, which was attributed to the 
formation of stable C-O-C covalent links between NADH and catechol moieties, arising from 
the coupling between radical species.[461] A similar NADH-induced inactivation process was also 
observed by Kuwana and coworkers on 3,4-dihydroxybenzylamine covalently bound to GCE. In 
contrast with NADH, ascorbic acid (AA) did not lead to electrode inactivation after successive 
redox cycles.[476] 
The electropolymerization of catechol and small catecholic derivatives has been investigated 
widely because of its affordability and convenient solubility in biological media, which allows 
the in situ preparation of films.[471] Abruña and co-workers studied the catalytic activity of 
electropolymerized films of 3,4-DHB on GCEs,[475] as well as other formyl-substituted o- and p-
dihydroxyaryl compounds.[465] Films were prepared by potential cyclization and deposition at a 
constant potential, the latter method affording the most stable ones. Catalytic activity toward 
NADH was strong enough to detect this species in the micromolar range.[494] In a later study, an 
alcohol sensor based on a NADH-dependent alcohol dehydrogenase enzyme was developed. 
Undesired interference of ascorbic acid in the measurements was eliminated by adding 
ascorbate oxidase, either in solution or immobilized on a nylon mesh.[495] Using an alternative 
linking strategy for 3,4-DHB, the Schiff base of this compound and 4-aminopyridine was 
deposited on a Pt electrode, affording an electrocatalytic SAM for the oxidation of NADH.[462] 
By means of a similar strategy, Chen and co-workers used a cysteinamine-glutaraldehyde 
conjugate monolayer on a Au electrode to immobilize dopamine for the same purpose.[463] 
Catechol and several catechol derivatives have been electropolymerized on GCE, yielding 
polymeric films that retain redox properties, as opposed to passive films obtained on metal 
electrodes. When this process was carried out in the presence of 1,3-diamines reactive toward 
o-quinoid species, the redox activity of these films was observed to change significantly.[471] 
Advantage was taken of the reactivity of o-quinoid species, in this case toward different 
thiolated aminoacids, by Compton and co-workers to devise a protocol for the selective 
electrochemical detection of cysteine in the presence of with little interference from cystine, 
homocysteine and glutathione.[496]  
Heterocyclic o-quinones with structures reminiscent of PQQ have been explored by different 
groups,[466,497,498] as electrocatalytic species for NADH and other species. In an early study, 
Abruña and co-workers showed that mixed-ligand transition metal complexes with 2,2’-
bipyridine (bpy), 1,10-phenanthroline (phen) and 1,10-phenanthroline-5,6-quinone 
(phendione), such as [Ru(bpy)2(phendione)]
2+, catalyze the oxidation of NADH in solution. The 
strongest effect was observed for a thin film of [Os(phen)2(phendione)]
2+ on a pyrolytic 
graphite electrode.466] Further investigations with similar complexes, such as [Fe(phen-
dione)3]
2+,[499] and [Re(phen-dione)3]
2+,[500] afforded electrodeposited thin films on GCEs that 
showed a dramatic catalytic effect, together with good stability, with no interference of 
ascorbate. An ethanol biosensor was fabricated by immobilizing an alcohol dehydrogenase 
enzyme on a nylon mesh and using the iron-phenanthrolinedione complex deposited on the 




7.2. Other biosensing electrodes. 
Valdés and co-workers studied the catalytical activity of dopamine, noepinephrine and 3,4-
dihydroxybenzylamine in solution toward a FAD/FADH2-dependent glucose oxidase. In view of 
the catalytic effect, it was suggested that the electrochemical degradation of catecholamines 
to yield indolic structures by intramolecular reaction might be diminished by rapid reaction of 
the oxidized catecholamines with the FADH2 cofactor. The authors reported the development 
of a method to detect catecholamines by adapting an electrochemical sensor with immobilized 
GOx on graphyte electrodes to a HPLC flow-cell.[477] In another approach to the detection of 
dopamine, Rivas et al reported the generation of a stable melanin-like film of 
electropolymerized L-DOPA on a glassy carbon electrode in such conditions that the film 
surface was rendered negatively charged, which allowed the exclusion of anionic species as 
potentially interfering with the analysis of species of interest, such as catechol and several 
catecholamines. Ascorbic acid was used in solution to amplify the oxidation signal in the 
detection of dopamine down to 5 nM.[479] Ensafi and co-workers prepared a modified carbon 
paste electrode by mixing graphite, carbon nanotubes and a catechol derivative acting as a 
redox mediator for the determination of antihypertension drug captopril in pharmaceutical 
preparations and urine, taking advantage of the redox properties of the terminal -SH group in 
captopril. Differential pulse voltammetry using such electrode showed improved sensitivity 
toward established analytical methods, as well as a high selectivity, even in real (urine) 
samples.[489] 
Kim and co-workers fabricated a lactate dehydrogenase screen-printed biosensor in which the 
printing ink was formulated with graphite, NADH, L-lactate, a hydroxymethylcellulose-ethylene 
glycol polymeric matrix and 3,4-DHB as electron shuttle. The detection limit thus achieved (50 
U/L) closely approached the clinically lower range of concentration (40 U/L).[501] The same 
redox mediator was chosen by Weiss and co-workers to design the first reagent-less 
dehydrogenase-based biosensor for monitoring phenylalanine in human urine. In this study, 
3,4-DHB was directly mixed with the carbon paste, instead of being used to modify the surface 
of the electrode with an electroactive film. Because of this, this electrode could be easily 
regenerated by simple polishing.[469]  
A sophisticated approach was devised by Scheller and co-workers in order to develop a high-
sensitivity biosensor for alkaline phosphatase, in which this enzyme converted phenyl 
phosphate into phenol, which was subsequently transformed into catechol by means of a 
tyrosinase. Catechol then entered an amplification sensing loop comprising several mutually-
coupled redox cycles; among these one in which this species was reversibly oxidized to o-
benzoquinone, and rapidly regenerated by a PQQ-dependent glucose-oxidase. This biosensor 
was successfully applied to the fast detection of traces of a pesticide by means of a 
competitive ELISA assay, showing enough sensitivity to comply with the limits established by 
the European legislation.[ 502 ] More recently, Lorenzo and co-workers fabricated a DNA 
biosensor based on [Os(bpy)2(phendione)]
2+  and [Os(phen)2(phendione)]
2+. A single strand of 
DNA was thiol-immobilized on a gold electrode and then allowed to hybridize with a second 
strand. Finally, the phendione complexes were electrodeposited on the Au electrode and 
differential pulse voltammetry recorded. The authors observed a significant change in peak 
electric current only for DNA strands hybridized with complementary sequences.[498] 
 
7.3. Enzymatic biofuel cells. 
o-Quinoid Pyrroloquinoline quinone (PQQ) has been extensively investigated as a redox 
mediator for enzyme-based electrodes and biofuel cells. In an early study, Katz and co-workers 
prepared covalently immobilized PQQ on Au and Pt electrodes and demonstrated the 
reversibility and stability of this modified electrode over a wide pH range.[503] The catalytic 
activity of the electrode-bound co-factor towards the oxidation of NADH was significantly 
enhanced by the addition of Ca2+, reminiscent of the enzymatic in vivo oxidation mechanism. 
[504] Later, Willner and co-workers fabricated a functioning enzyme-less biofuell cell by using a 
PQQ-modified electrode as anode.[505] Simultaneously, this research group made a significant 
brakethrough in the development of enzymatic biofuel cells by means of a “reconstitution 
strategy”: The cofactor of a redox protein was carefully extracted, covalently linked to an 
electrode in a self-assembled monolayer –either directly, or through a suitable redox mediator, 
such as PQQ-, and finally joined back with the apo-enzyme. This approach ensured a good 
electrical contact between the redox protein and the electrode, while at the same time 
preserving the redox activity of the protected, still-functional cofactor.[506] In follow-up studies, 
PQQ was successfully used as redox mediator, electrically connecting Au electrodes with FAD 
and NADH cofactors for glucose oxidase (GOx)[507,508] and lactate dehydrogenase (LDH) -based 
electrodes,[509] respectively. After the optimization of the Au – PQQ - cofactor connection,[510] 
the turnover rate of the associated glucose oxidase reached that of this enzyme with its native, 
in vivo O2 electron acceptor.
[511]  
More recent research of the Willner group focused on the functionalization of Au 
nanoparticles[512] acting as last electrical relays in modified electrodes. In one study, PQQ itself 
was chosen as redox cofactor –instead of mediator-, for the fabrication of a glucose 
dehydrogenase-based electrode that showed high enzymatic turnover rates and efficient 
electric contact between the protein and the electrode, albeit also a considerable oxidation 
overpotential.[513] Following another line of research, Fe3O4 NPs were linked to PQQ relays and 
NADH cofactors. In this case, the modified NPs were not covalently attached to the Au 
electrodes, but were instead suspended freely in the medium. It was shown that the catalytic 
activity of the enzyme, which as usual relied on the electrochemical regeneration of the 
cofactor, could be switched off by dragging the NPs away from the electrode by means of a 
magnetic field, and subsequently turned on when the field was reversed and the NPs 
approached and eventually contacted the anode.[ 514 , 515 ] Finally, this research group 
demostrated that a small enhancement in the catalytic activity of NAD/LHD-based biofuel cells 
using PQQ as mediator redox species was observed when a constant magnetic field was 




A few catechol-based molecules have been found useful in the selective sensing of certain 
“difficult” species, such as ammonium cation[517] and biologically relevant Mo, W, and V 
oxometalates. In this case, a catechol moiety was covalently linked to a luminescent Re 
coordination complex.[518] Upon complexation of the oxometalates at low pH, the catechol 
deprotonated and luminescence was quenched. This effect was not observed in the presence 
of other common transition metals that coordinate catechol efficiently, but do so at higher pH 
values, such as CoII, NiII, CuII, ZnII, and FeIII.[519] Dioxometalate complexes with substituted 
catechols afforded as well receptors with strong affinity for glutaric and glutamic acids,[520] and 
short-chain diammonium salts.[521] In addition to metal cations and organic species, catechol 
derivatives have been used as sensor moieties for a few anions. Simple molecules like 
pyrocatechol itself have been shown to associate favorably to halides via hydrogen bond. The 
effect was strong enough to be competitive with the chloride-binding capacity of a reference 
amide compound, as detected by 1H-NMR.[522] When catechol moieties were supported, 
siderophore-like, in a scaffold of appropriate geometry and flexibility, the affinity of the ligand 
toward Cl- outperformed that of pyrocatechol.[523] Fluoride could be detected selectively with 
catechol-chromophore conjugates,[524,525,526] in which case both hydrogen-bond and acid-base 
mechanisms were claimed to explain the binding effect. Catechol-based anion recognition and 
transport in biological media has also been researched. Two catechol moieties were linked to 
scaffolds of variable amphiphilicity, showing that the molecules are able to catalyze anion 
transport through liposome membranes. The selectivity observed for the optimized bis-
catecholic compound with regard to the anion transport followed the sequence ClO4
- > I- > 
NO3
- > Br- > Cl-, which correlated to their relative hydration energies (Hofmeister effect), as 
seen for many natural anion transport mechanisms. Also, the bis-catecholic transporter 
seemed to associate on the membrane at high concentrations, making the anion transport 
more efficient.[527] 
Finally, the synthesis and characterization of a new family of catechol derivatives designed to 
behave as fluorescent chemosensors for wide-range pH detection has been described.[528] 
These compounds were prepared by covalently coupling a catechol unit with other aromatic 
rings, thus obtaining -delocalized systems with both pH-responsive groups and fluorescent 
behavior. In the case of a pyridine–catechol derivative, this leads to up to three different 
protonation states with distinct optical properties in organic media, as corroborated by density 
functional theory calculations. By applying dualwavelength detection techniques, this 
compound shows complementary “off–on–off” and “on–off–on” emission profiles upon pH 
variation, a behavior that can be exploited to perform acidity detection over a broad pH range. 
The same authors also reported a new synthetic route for the synthesis of a sterically 
protected azobisphenol, obtained upon reaction of two catechol units, which exhibits a three-
stage sensor capacity. The reversible deprotonation/protonation of the phenol groups has 
been shown to take place under basic and acidic conditions, respectively. Moreover, this 
compound also exhibits good reactivity with transition-metal ions such as cobalt. Accordingly, 
combination of both the acid–base character and the complexation ability have been used to 
create a chromophoric array of three states with significantly different colours (enhanced by 
the presence of the azo group), which can interconvert reversibly between them.529] In 
addition to the studies on bulk solutions, these families of compounds have alwso been 
structured on surfaces for the development of a surface molecular sensor for the detection of 
acidity. Initially, lithographically controlled wetting deposition has been applied to 
nanostructure a new fluorescent compound with three protonation states featuring different 
optical properties on a glass substrate. Atomic force microscopy demonstrates the 
functionalization of the surface with ordered arrays of the sensor molecules. The fluorescence 
properties of the resulting nanopattern at different pH values have been investigated by 
confocal fluorescene microsopy, thus revealing the fast, sensitive, reversible response of the 
prepared nanosensor to gas flows of varying acidity.[530] Arrays of fluorescent pH-responsive 
multistate molecules on surfaces have been fabricated by means of other soft lithographic 
techniques, such as CP. Direct physisorption onto the desired surface can be attained in a 
very simple manner, without the need for tedious modification of the molecular systems 
neither of the supporting platforms. However, the arrays lack of the stability required to be 
used with liquids. This situation is solved by the use of covalent bonding though this requires a 
previous functionalization of both the molecule and the surface. Interestingly, their acid–base 
switching behavior remains once structured on a surface with small variations of their 
emission spectrum. In this way, the patterns generated have shown fluorescence sensing 
capabilities when they are exposed to atmospheres of different acidity over large pH-windows. 
These results open the door to the development of novel molecular-based sensing capabilities 
thanks to their fast responses.[531] 
  
8. Switching materials 
 
8.1. Electronically labile transition metal complexes. 
The term of non-innocent ligands directly related to their role and the influence on the final 
electronic distribution of certain transition metal complexes was first pointed out by 
Jørgensen.[532] This concept can be used when both the metal and ligand-centred electronic 
frontier orbitals are similar in energies. Within such scenario, the final oxidation state of the 
complex and the internal electronic distribution may be modulated becoming a great subject 
of investigation both by theoretical,[533] and experimental means.[534] One of such families of 
non-innocent ligands is that of o-quinone ligands, which can be found in transition metal 
complexes in two different oxidation states, radical semiquinones (SQ-) or dianionic 
catecholates (Cat2-). There would exist a third oxidation state, a neutral quinone (Q), though it 
can hardly be found coordinated to metal ions due to the limiting binding ability of the 
quinone ligand.[535] Thanks to this rich redox activity, in some complexes bearing electro-active 
metal ions it is possible to induce an intramolecular electron transfer (IET) between the 
catechol and the metal ion by means of different external stimuli, mainly temperature, though 
also by light or pressure. The interest for studying this family of complexes is considerable 
since they are unique model systems which provide insight into the basic factors affecting 
intramolecular electron transfer. For this reason, this family of complexes is of great relevance 
on the field of molecular electronics as well as on the study of complexes bearing non-
innocent ligands that perform physiological functions on biological systems. Both approaches 
are revised next. 
8.1.1. Molecular Electronics 
Valence tautomeric (VT) metal complexes with at least two redox-active centres, the metal ion 
and a catechol-based ligand, are characterized by the existence of two electronic isomers 
(valence tautomers) with different charge distributions.[536] The interconversion between the 
different electronic isomers is accomplished by a reversible intramolecular electron transfer 
involving the metal ion and the redox active ligand. For this to take place, the degree of 
covalency in the interaction between the metal and the ligand must be low whereas the 
matching between the energy of their frontier orbitals similar.[537] The first description of the 
above mentioned charge distribution sensitivity was the cobalt bis(quinone) complex [CoIII(3,5-
DTBCat)(3,5-DTBSQ)(bpy)] (X),[538] where 3,5-DTBCat2- and 3,5-DTBSQ- refer, respectively, to 
the catecholate (DTBCat2-) and semiquinonate (DTBSQ-) forms of 3,5-di-tert-butyl-o-quinone, 
and bpy is 2,2’-bipyridine. In solution, the equilibrium in Equation 1 can be induced by 
variations of temperature and monitored by magnetic measurements and spectroscopic 
techniques such as UV–VIS, NMR and/or EPR. Since then, several other examples of 
monomeric, dimeric and even polymeric VT materials with not only cobalt but a series of 
transition metal ions such as Cu, Rh and Ir, Ni and Mn have been reported most of them being 
compilated in different reviews, to which the reader is further referred.[539] Suffice it to say an 
introduction to the origin and behavior of this interesting family of switchable materials with 
emphasis in some specific aspects, mainly description of the different external stimuli that can 
be used for the interconversion, redox characteristic of different catechol-based Ligands and 
influence of the macroscopic state and matrix environment on the VT equilibrium. 
[Co
III
(3,5-DTBCat)(3,5-DTBSQ)(bpy)] (x,ls-Co(III))   [Co
II
(3,5-DTBSQ)2(bpy)] (x,hs-Co(III))   (1) 
VT is an entropy-driven process due to the higher spin state degeneracy and the higher density 
of vibrational states of the hs-Co(II) form due its longer metal-ligand bond lengths.[540] Thus 
thermal population of tautomeric states is dictated by the Gibbs free energy expression. At low 
temperatures, T S is negligible compared to H, and consequently if H>kT only the ls-Co(III) 
state is populated. An increase of the temperature will increase the T S contribution, making 
it non negligible and favouring the population of the hs-Co(II) state, up to a critical 
temperature Tc where G = 0 and H =T S. A further increase of the temperature will change 
the sign of G, being the hs-Co(II) the most populated state. It is important to emphasize that 
VT can be induced not only by temperature variations but also by irradiation, as pioneered by 
Hendrickson[541] and Dei,[542] both in solution and in the solid state.[543] Examples of pressure-
induced VT have also been reported although in less extent than thermally-driven or light-
induced transitions. In these experiments, the increase of the molecular size on passing from 
the low to the high-spin isomer due to the population of antibonding orbitals is used to favour 
the low-spin isomer after application of pressure as an external stimulus.[544]  
In addition to the use os different external stimuli, another area of special interest has been 
the finding of new redox-active Ligands that also show VT phenomena.[545] A further step in 
this sense has been the study and characterization of catechol-based O,N,O-coordinated type 
ligands containing two phenolate donor groups such as ligand BQ-N-SQ .[546] These ligands, in 
addition to producing phenoxyl radicals in the presence of air, exhibit better chelating 
capabilities and good π-donor atoms that stabilize higher oxidation states.[547] The synthesis 
and mechanical features for the obtaining of the ligand BQ-N-SQ was first described in 1975 by 
Girgis and Balch,[548] treating the 3,5-di-tert-butyl-catechol with aqueous ammonia in the 
presence of a divalent metal ion under aerobic conditions. Since then, a considerable interest 
has increased in the scientific community for this family of complexes. Thanks to their rich 
redox activity, these ligands may exist at least in four different oxidation states although 
structural and magnetic characterization of the complexes bearing this ligand suggest that they 
can be mostly found as MIV(Cat-N-SQ)2, MIII(Cat-N-SQ)(Cat-N-BQ) and MII(Cat-N-BQ)2. The first 
complex of this family reported to exhibit VT was complex [CoIII(Cat-N-BQ)(Cat-N-SQ)].[549] 
Although first reported in 1988 by Pierpont et al., no evidence for tautomeric interconversion 
was shown to take place at that time.[550] A few years later the interconversion was also shown 
to take place in solid state though at much higher temperatures,[551] and even the coexistence 
of at least two different IET phenomena, ligand-to-metal and ligand-to-ligand.[552] 
[CoIII(Cat-N-BQ)(Cat-N-SQ)]         [CoII(Cat-N-BQ)2]         (2) 
Afterwards, valence tautomerism has also been reported for the related manganese complex 
[MnIV(Cat-N-SQ)2].
[553] Whereas its solid-state structural features are in agreement with the 
electronic distribution that involves the manganese atom in its oxidation state (IV), its solution 
temperature-dependence shows that this complex exhibits valence tautomerism involving 
three different tautomeric isomers associated to the three different oxidation states of the 
manganese ion: Mn(IV), Mn(III) and Mn(II). The advantages of valence tautomeric Schiff base 
complexes over transition metal complexes with o-quinone ligands are considerable. First, 
valence tautomeric Schiff base complexes display higher stabilities relative to atmospheric 
oxygen atmosphere in solution and solid state. Second, the differences between the optical 
properties of isomers involved in the valence tautomerism of the cobalt Schiff base complex 
are enhanced when compared to those observed for cobalt complexes with o-quinone ligands. 
Third, the Schiff base ligand exhibits a richer electrochemical behavior since it can exist in 
different oxidation forms, ranging from +1 to –3, which may lead to stable coordination 
complexes with several metal ions in a variety of oxidation states. 
The redox activity of the ligands not only allows for the existence of valence tautomerism but 
also for additional switching capacities resulting from an electrochemical process. Such a 
strategy has been shown to be very useful for the systematic tuning of the critical temperature 
at which there are equal amounts of both tautomers, as well as to establish arrays of several 
different states depending on the redox possibilities of the metal ion involved in the array. The 
first example of redox-tuned valence tautomerism was based on the reduction of complex 
[CoIII(3,5-DTBCat)(3,5-DTBSQ)(bpy)].[ 554 ] Interestingly, the resulting reduced complex also 
exhibited a temperature-dependence consistent with the existence of a valence-tautomeric 
equilibrium. This fact allowed for the first time to establish an array of four states showing 
different optical and magnetic ground states controlled by two temperature-controlled 
valence tautomeric equilibria and two reversible redox processes. The possibility of entering 
the cycle at each state and advancing through the square array in a clockwise and counter-
clockwise direction was also established. Following this approach, Rovira et al.,[555] also 
established an array of four states based on the oxidation of the tautomeric complex [CoIII(Cat-
N-BQ)(Cat-N-SQ)]. Interestingly, the variable-temperature absorption spectra of the charged 
species [CoIII(Cat-N-BQ)2]
+ chemically formed upon partial oxidation showed a equilibrium 
consistent with a temperature-induced valence tautomerism shown in Equation 3. This fact 
allowed the establishing of an array of four states showing different optical and magnetic 
ground states by using a reversible oxidation process as additional stimulus. 
[CoIII(Cat-N-BQ)2]
+     [CoII(Cat-N-BQ)(SQ-N-BQ)]+     (3) 
It is also important to emphasize that the presence of VT in a given complex has been 
traditionally associated almost exclusively to the role played by the the redox-active ligand and 
the transition metal ion. However, the existence of several other factors that can modulate the 
observation of VT has also been detected along all these years of research in the field.[556] In 
other words, the same complex may exhibit or not, or the VT process can be shifted to much 
higher temperatures, depending on other structural and environmental parameters such as 
nature of the counter-ligand, charge-induced and environmental effects.[557] One of the 
approaches recently followed to avoid such critical effects on a rerproducible manner has been 
the development of VT polymeric nanoparticles that exhibit the same behaviour 
independently whether if they are suspendend in a solution, polymeric matrix or solid state. In 
this sense, Ruiz-Molina et al. demonstrated that precipitation/coordination polymerization is a 
suitable approach for the fabrication of pre-synthesized units into functional metal–organic 
nanoparticles. Size-tunable nanoparticles that exhibit valence tautomerism have been 
obtained by using electroactive [CoIII(3,5-dbsq)(3,5-dbcat)] units and the appropriate bridging 
ligand. Such a bridging ligand or polymerizing agent was previously shown by others to be 
crucial to the formation of nanoparticles. Whereas the bix ligand yields amorphous 
nanoparticles, the 4,4’-bipyridine ligand yields a crystalline material. The high flexibility of this 
strategy and its scalability to several different functional molecular materials will certainly 
expand the synthesis of VT materials with novel morphologies and working ranges by simple 
polymerization of functional units/clusters and metal ions with the appropriate bridging 
ligands.[558] 
Finally, the comprehension and understanding of the characteristic features for all these VT 
complexes has been developed in parallel over the last decades, rising out a large interest in 
the scientific community as demonstrated by the large amount of examples developed for 
each case. From a fundamental approach, VT complexes represent a unique scenario to study 
IET in model molecular materials involving both redox-active Ligands and transiton metal ions. 
From an applied perspective, the large changes in the optical, structural, and magnetic 
properties that often accompany the valence tautomeric interconversion have potential 
applications in the development of molecular electronic devices that can be used as optical 
and/or magnetic data storage media. 
8.1.2. Physiological functions and related models 
Transition metal complexes where the internal electronic distribution may be modulated by 
different external stimuli are of interest not only for the field of valence tautomerism but also 
for several other fields such as the study of complexes bearing non-innocent ligands that 
perform physiological functions on biological systems. In this sense, transition metal 
complexes in which one or more of the ligands is present as a phenoxyl radical have attracted 
much interest due to their occurrence in enzymatic metalloproteins such as galactose oxidase 
(GAO)[559] or glyoxal oxidase (GLO).[560] Other examples of such electronic lability in Nature 
involves the Cu(I)/Cu(II) pair found in a copper containing enzyme that catalyzes the oxidation 
of amines to aldehydes,[561] an important process in relevant biological functions such as 
growth regulation and tissue maturation. Model studies have also been done by Speier et al., 
who described the existence of valence tautomerism for the species [Cu(py)2(PhenQ)2]
[562] and 
Kaim et al., who reported the use of a weak π-acceptor thioether in a Cu(I)-semiquinone 
complex to induce valence tautomerism as a paramagnetic compound associated to amine 
oxidase enzymes.[563] The acceptor characteristics of the counterligand in a series of copper-
quinone synthetic model with the general formula [(Qn-)Cun+L] have also been studied. Strong 
π acceptor ligands such as L=CO, CNR, PR3 or AsR3 stabilize the Cu(I)-semiquinone form 
whereas the use of non-π-acceptor ligands, such as amine ligands, favour the Cu(II)-
semiquinone form.[564] For instance, Buchanan et al.,[565] have demonstrated the possibility to 
modulate the charge distribution between the two electronic isomers [L2Cu
II(3,5-DTBCat)] and 
[L2Cu
I(3,5-DTBSQ)] by changing the nature of the counter-ligand from a strong nitrogen donor 
to a soft phosphine donor. On the other side, Kaim et al.,[566] have also reported the use of a 
weak π-acceptor thioether to induce sensitive valence tautomerism in paramagnetic copper 
complexes related to amine oxidase enzymes. In a more recent study, the comparison 
between two thioether ligands that differ on their π-acceptor capacity and structural rigidity 
has been used to have a comparative study of both effects.[567]  
Another nice example for the relevance of this molecular systems is their influence on the 
catalytic center of citochrome c oxidase (CcO). The substitution of the tyrosinate cross-linked 
for a semiquinone group have generated a long-lived imidazolyl-phenoxyl radical.[568] The 
resulting complexes with the general formula (Cu-imidazolyl-phenoxyl) are created to mimic 
the CuB
II-histidine-tyrosinate center in an attempt to study its catalytic potential on biological 
processes. A nice example of the formation of such mimic models is complex [(tpa)Cu(Im-
hq*H2)](OTs)2 complex. The study of its double deprotonation show the evidence of the free 




8.2. Dye-sensitized solar cells. 
Catechol has long been known for its strong affinity for metal ions with high oxidation states 
and/or high charge to metal ion radius ratios, such as FeIII. In this regard, catechol shows a 
comparably high affinity for TiIV,[569] which would make dihydroxyaryl moieties, and enediols in 
general, excellent choices as robust anchors for photosensitizing dyes in Grätzel’s TiO2-NP-
based dye-sensitized solar cells (DSSCs).[570] Anchorage of the catechol molecule to TiO2 
surfaces has been subject to detailed experimental research,[15, 571,572] showing that it is capable 
of bidentate binding to TiIV.[573,574,575] In addition to their prominent role as anchors (Sections 1 
to 4), catechol moieties play an additional role as small-molecule sensitizers, playing a central 
role in the performance of the DSSC.[576] In this regard, catechol has been shown to afford a 
very strong electronic coupling between the chromophore and the semiconductor, which is in 
contrast to those of weaker binding moieties, such as carboxy or phosphate groups.[577 This 
strong coupling manifests itself in the appearance of a new absorption band at around >400 
nm in colloidal TiO2-catechol complexes,
[571,575, 578 ] also observed in other TiO2-enediol 
complexes.[579] Recent semiempirical,[580] and ab initio calculations[581,582] have shown that this 
band may be assigned to a photoinduced electron transfer (ET) from the HOMO - , dye-
localized- orbital to a hybrid orbital in the conduction band (CB) of the semiconductor that 
participates both of catechol and Ti (3d) orbitals, and lies below the dye-localized, * excited 
state.[580, 574] Therefore, whereas for so-called Type I DSSCs, electrons are first promoted upon 
photoexcitation to a dye-localized excited state, and subsequently injected into the conduction 
band of the semiconductor, in so-called Type II DSSCs, -such as catechol-TiO2 complexes-, 
electrons may be injected as well directly into the CB of the semiconductor.[580583] Although 
such a direct injection mechanism should be, in principle, extremely fast,[ 584 ,575] and 
theoretically 100% efficient,[583] the strong electronic coupling may be also conducive to 
competitive charge recombination –or back electron transfer-, which dramatically decreases 
the net, dye-to-semiconductor ET efficiency.[583] 
Several studies reporting the use of catecholic anchors/sensitizers have been published in the 
past years, in which catecholate sensitizer/anchors have been coupled to a variety of 
semiconductors – mainly TiO2,
[585,576,586] but also ZrO2,
[587] ZnO[588,589] and NiO -.[590] In all cases, 
these reports evinced a difficult compromise between strong electron coupling and 
concomitant detrimental back electron transfer. Ward and co-workers already showed that 
the grafting properties of catechol-Ru complexes to TiO2 surfaces were better that those of 
similar, high-efficiency Ru-based dyes featuring carboxylic acid groups as anchoring moieties, 
which are more prone to desorption from the NP surface, particularly at acidic pHs. 
Nevertheless, lower photocurrents and overall electron transfer efficiencies were obtained for 
the catechol-anchored dyes in comparison, which was then attributed to aggregation of dye 
molecules on the metal oxide surface.[585] Ghosh, Das and co-workers have investigated in 
detail the photoexcitation and relaxation kinetics of several catechol-anchored metallorganic 
dyes, reporting first on a RuII-terpy dye connected to a catechol moiety by means of a 
conjugated double bond. The authors observed fast back electron transfer in spite of an 
ultrafast electron injection, leading to lower overall efficiency.[576] When Os was used instead 
of Ru, direct excitation to triplet states with lower energy was observed, which enabled the 
extension of the excitation range to the red region of the solar spectrum,[587] and led to slower 
charge recombination.[591] Following Grätzel’s approach for the “black dye”, SCN ligands were 
also incorporated in RuII-bipy-catecholate-TiO2 complexes, which extended light absorption 
into the NIR range.[586] The strong electronic coupling afforded by catecholate moieties was 
further evinced when solvatochromic ligands, such as CN, where used in catechol-bound RuII 
complexes; the solvatochromic effect dramatically diminished.[592] Recently, the same authors 
introduced a dimethylaminophenyl substituent as -electron donor in one of the bipy ligands 
of a polypy-RuII-catechol dye, aimed at facilitating delocalization of the positive charge in the 
RuII-ligand sphere upon electron transfer, thus contributing to a greater spatial charge 
separation, and in turn to slower back electron transfer dynamics. With regard to the original 
RuII-catechol complex, the dimethylaminophenyl-substituted complex showed a 20% higher 
efficiency in the electron injection yield, without impairment of the electronic coupling of the 
dye to the TiO2 nanoparticles. The beneficial effect of the ligand disappeared at vey low pHs, 
which was explained by the fact that the amino group responsible for the charge delocalization 
becomes protonated in these conditions, giving further proof of its role in the increase of 
charge separation.[593] Similar results have been recently observed for RuII-dye-catecholate 
complexes with other conjugated electron-donating moieties.[594] 
Yoon and co-workers reported a notable increase in net injection efficiency through the design 
of ligands with conjugated electron-donating groups for RuII-dye-catecholate complexes,[383] to 
which similar studies by other groups followed.[593,594] Another approach involved coating of 
the semiconductor NPs with a nanometer-thick SrTiO3 shell barrier,
[595] which led to a 70% 
improvement in charge collection at the interface. Finally, Burn, Meredith and co-workers 
prepared thiophene-catechol sensitizing moieties with 1, 2 and 3 conjugated thiophene units. 
Although conversion efficiencies increased slightly with the extension of the conjugation, the 
authors observed that charge recombination depended strongly on dye loading, the former 
being more severe as dye surface coverage the TiO2 NPs increased.
[596] Theoretical calculations 
on such systems suggested that the extension of the conjugation should enhance the cell 
efficiency due to an increase in light absorption, despite a lesser increase in opposing charge 
recombination.[597] 
In addition to RuII-dye complexes, catechol-anchored porphyrin dyes have been studied, 
showing a rather complex behavior,[598] which was notably affected by the degree and type of 
aggregation between porphyrin units in solution.[599] Particularly, photoexcitation decay for 
aggregates was found to be much slower than those of single, unaggregated dye molecules on 
TiO2 NPs. This was attributed to the stacking of porphyrin units, which effectively delocalized 
the positive charge after the electron transfer, separating it from the electron (negative 
charge) injected on the TiO2 surface, and thus slowing down the back electron transfer 
process.[ 600 ] Other catechol-like systems investigated include alizarin,[584, 601 ,581, 602 ] 
dopamine[603,604] and, from a theoretical standpoint, anthraquinone and xanthene dyes with 
catechol groups.[605] Despite its catecholic structure and bidentate hydroxyl-mediated binding 
to the TiO2 surface, alizarin did not give rise to direct electron injection in the conduction band 
of the semiconductor, likely due to the spread of the * orbital over a greater molecular area, 
and thus a lower mixing of this dye excited state with Ti orbitals.[577,582] On the other hand, 
electron injection to the conduction band (6 fs) was among the fastest ever recorded for any 
DSSC,[584] which was explained by the proximity of the dye photoexcited state to the lower 
edge of the conduction band of the semiconductor.[602] 
Hirsch, Peukert and co-workers reported the modification of ZnO nanoparticles with a Zn 
porphyrin, attached to the NP surface through two different catechol-based spacers. It was 
shown that catechol groups communicate electronically the porphyrin moiety and the ZnO NP, 
so that the porphyrin-based coating served as efficient fluorescence quencher of the ZnO 
surface emission.[588] In a follow-up study, the authors bound cationic dendrons with catechol 
anchor groups on the surface of ZnO quantum dots, which were thus successfully modified to 
avoid aggregation. These QDs were further incorporated as mesoporous films in a proof-of-
concept DSSC design by coupling them to oppositely-charged porphyrins.[589] 
 
8.3. Miscellaneous devices. 
Nuckolls and co-workers reported that 1,2-dihydroxytetracene self-assembles on aluminum 
oxide by spontaneously forming dense -  stacks, perpendicularly oriented to the surface and 
anchored through the catecholic bidentate end. The tetracene monolayer was shown to make 
up an active channel for hole transport in a nanoscale field-effect transistor device, with the 
Al2O3 surface acting as dielectric layer.
[ 606 ] Pickup et al. designed an asymmetrical 
supercapacitor, in which an anthraquinone-modified carbon (negative) electrode was coupled 
to a catecholdiazonium-modified carbon (positive) electrode, and separated by a dielectric 
perfluorinated membrane. This capacitor was shown to double the energy density of an 
analogous, carbon-based symmetrical capacitor, while at the same time providing a lower-cost 
alternative, since the catechol derivative substituted for commonly used, but also more 
expensive Ru oxide electrodes.[607] 
Ward and co-workers have investigated the electrochromic properties of catechol derivatives 
designed to have reversible and selective light absorption in the NIR region upon the 
application of suitable redox potentials (electrochromic windows). In a first report, the authors 
described the electrochromic properties of a Ru(bipy)2(TCC) complex (TCC=tetrachloro-
catecholate) that showed intense, electroreversible absorption in the NIR (ca. 1000 nm). When 
a monolayer of this compound was deposited on a nanocrystalline Sb-doped tin oxide 
electrode and a switching potential was applied, the light absorption properties changed 
almost completely within ca. 1.5 s.[608] More recently, the electrochromic properties of two 
Ru(bipy)2(HHTP) complexes (where HHTP is the symmetrical tricatecholic 
hexahydroxytriphenylene), differing only in their solubility in organic/aqueous media, were 
studied. These compounds exhibited a completely reversible electrochemical behavior 
affecting the HHTO moiety, and exceptionally intense transitions in the NIR (ca. 1100 nm) 
when in the fully (tri-) semiquinonic state, which completely disappeared once the HHTP 
moiety was switched back to the fully reduced (i.e., tricatecholate) state. Films of these species 
were prepared on indium tin oxide-coated glass and shown to be able to switch their 
absorption in the NIR reversibly and relatively fast upon application of commutating electric 
potentials. For one of the two complexes, reversibility was maintained up to 83% after 24 h (> 
4000 redox cycles) on account of its poorer solubility and, thus likely, a decreased loss of 
material during operation in an aqueous environment.[609] Using a bis-catecholic ligand 
(tetrahydroxyfluorone) capable of simultaneously binding two Ru nuclei, Natali et al. 
fabricated a proof-of-concept device capable of resolving NIR light pulses as short as 20 s.[610] 
Suitable chelating agents may be used to alter the binding geometry of under-coordinated 
surface atoms in order to restore optimal, fully coordinated geometries. Comparison between 
the spectroscopic features of unchanged and modified surfaces allows the identification of 
structural defects localized on surface atoms.[611,612] Using this approach, Chen, Rajh and co-
workers chose dopamine to study in detail the surface defects of Fe2O3 nanoparticles by XANES 
(X-ray absorption near-edge structure) spectroscopy, and distinguish them from other defects 
arising from the interior of the nanoparticle.[613] Recently, the same group investigated 
different catechol derivatives as surface modifiers of metal oxides (TiO2, ZrO2, CeO2, Fe2O3) 
that were irradiated with laser light, showing that these ligands enhanced Raman scattering 
significantly. This effect was also observed in bioconjugated systems were a biomolecule of 
interest is linked to the oxide surface through a catechol moiety, hinting to the potential of 
these systems for biomedical assays.[614,615] 
An example of switchable catechol-based films is that of oxidized catechol-chitosan conjugates 
studied by Payne and co-workers.[616] It was shown that catechol-modified chitosan films, 
although redox-active, were not conducting but became so in the presence of redox mediators 
in solution (Fc(MeOH)2; [Ru(NH3)6]
3+). At fixed concentrations of the mediator, the CV signal 
intensity increased with increasing catechol content in the film (amplification factor), albeit not 
linearly, due to increasing cross-linking and concomitantly decreasing film permeability, while 
the electrochemical response showed partial rectification characteristics. Moreover, after 
depletion, the film's redox activity could be regenerated by immersing it in the proper 
mediator solution under anodic and cathodic conditions, which may thus be considered as 
switches for the redox activity of the film.[617] In a recent study, this research group showed 
that catechol-chitosan films can be made to be pH and voltage-responsive, being able to trap 
redox mediator pairs such as Fe(CN)6
3−/4− in acidic conditions and selectively releasing them at 
high pHs and/or negative electric potentials.618 
Nadeau and co-workers reported the first example of a cell-based biosensor based on electron 
transfer between a small molecule (dopamine) and CdSe/ZnS quantum dots (QDs). Dopamine 
moieties with their catechol rings facing outwards were covalently attached to QDs with 
different fluorescent emission patterns, and fluorescent quenching arising from charge 
transfer by dopamine species studied. Cells bearing specific receptors for dopamine were able 
to uptake selectively dopamine-functionalized QDs, which showed strong fluorescence in 
oxidizing intracellular environments, and quenched fluorescence in reducing ones. In these 
cases, fluorescence could be externally switched on by UV irradiation. Because of the inherent 
cytotoxicity of quinoid moieties, catechol-functionalized QDs exemplify the potential use of 
electro-donor/QD conjugates in QD photodynamic therapy.619 In a conflicting, more recent 
study, Medintz et al. studied the influence of pH on the photoluminiscence (PL) of similar 
dopamine-peptide CdSe/ZnS QD conjugates. The authors found that an increasing pH 
correlated with greater PL quenching in aerated environments, arising from the oxygen-
mediated oxidation of the dopamine moiety in basic media. This observation was replicated in 
a biological environment by microinjecting pH-buffered solutions of functionalized QDs in cells, 
where cytosolic pH could be thus related to normalized PL down to the single cellular level. In 
this case, then it was dopamine (instead of the corresponding quinone) the chemical species 
responsible for QD photoluminiscence.620 In the latest, detailed study on the PL quenching 
mechanism of dopamine-QD conjugates, ZnS-overcoated CdSe QDs were capped with polymer 
DHLA-PEG bearing certain number of dopamine pending groups. Conjugates showed 
increasing photoluminescence quenching in alkaline media that unequivocally correlated with 
the presence of oxygen in solution leading to the formation of a certain amount of quinoid 
species. PL quenching was attributed to the annihilation of the QD excited state through a 
combination of two electron transfer mechanisms, - from high-potential dopamine moieties to 
the valence band of the QD, as well as from the conduction band of the semiconductor to low-
potential quinone acceptors. 621  Finally, Santra and co-workers studied the covalent 
modification of CdS:Mn/ZnS QDs with outward-facing, thiol-coupled dopamine moieties and 
their potential use as sensors for glutathione. In absence of the analyte, the authors observe 
fluorescence quenching of the functionalized QDs, which is attributed to the presence of at 
least a fraction of quinoid (oxidized) species. When glutathione is added to the medium, the 
covalent bond between the dopamine/quinone layer and the QDs is severed, and the 
fluorescence of the latter restored.622  
Conclusions and Outlook. 
In terms of the number of academic and technological proof-of-concept studies published in 
the past years, catechol derivatives as key components of adhesives and bioadhesives have a 
very promising outlook. In this respect, not only do these materials already offer bioinspired 
alternatives with performance comparable to that of commercial super-glues, but also, 
biocompatible variants capable of adhesion in aqueous environments and with low 
immflamatory response. On the other hand, the versatility of polydopamine as easy-to-use 
universal primer has already spun a virtual explosion of scientific work that will no doubt keep 
on growing in the near future. Also promising is the quest for functional materials with more 
robust adhesive catecholic anchors, which should increase their chances at becoming 
commercially viable as functional coatings. 
Catechols still have much to offer in other areas, especially in those where it acts as a stimulus 
responsive material. One of the key points so far has been the control of the reversibility of the 
redox character of the catechol/quinone pair, which is obviously essential to achieve durable 
switching behavior. Whenever catechols manifest their messy, irreversible reactivity, they still 
present some interesting challenges, such as the final elucidation of the structure of melanins, 
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